When sales are good, meetings are short. – Mazi Sam Ohuabunwa, FPSN, MON, OFR
I believe in principles and strategies. Over the years, applying principles and strategies have enabled me to achieve outstanding results in my personal and professional life. I once developed what I call the selling champion’s 10-5-5 rule. The rule is a model that ensures high sales performance. I invented it after over 24 years of practical sales experience.
Explaining the rule
The 10-5-5 rule states thus:
The salesman should reach out to 10 prospects daily.
The salesman should reach out to 5 current customers daily.
The salesman should reach out to 5 old customers daily.
George O. Emetuche
The first category of prospects represents people who are yet to commence business with the salesman but there is hope that they could be converted to start buying his products. The model proposes that salesmen should reach out to 10 prospects that are within this category daily. This helps in discovering new buyers. Salesmen must try to develop a new market daily.
Current customers in the rule, as stated in number two, represent the people who are already buying from the salesman. The model encourages salespeople to visit at least five of this category daily. You can visit them for supplies, for follow ups, for introducing new products or services, for keeping in touch or for any other reason that could enhance the business relationship.
Old customers in the model, as stated in number 3, are people who were buying the salesman’s products before but stopped because of one reason or the other. Several reasons could make a company’s customer to stop buying from them. The reasons could be from the company, from the salespeople or as a result of reasons relating to poor services or failed promises. The reason could also come from the customer. The 10-5-5 rule proposes that salesmen should identify five contacts within this category and reach out to them daily, with a view of winning them back to start buying again.
Research has shown that it is six times more expensive to win a new customer than to retain an existing on. Reaching out to revive a business relationship is a smart approach.
Winning back an old buyer takes a process. But it is worth the effort. It usually requires that the company or salesman follow a procedure. The company is expected to come up with win-back strategies which should include ensuring a win-win business relationship. The company should also make adequate effort to make peace with such customers.
The 10-5-5 rule is a 360 degree approach
Successful sales professionals maintain a healthy sales reservoir. Your sales reservoir contains a database of your customers and prospects. The more you apply the 10-5-5 rule, the more you expand the reservoir. 10-5-5 rule recommends 20 sales calls daily. When you have a shortfall in implementing the rule, then take the shortfall to the next day and add to the day’s calls. You need a healthy sales reservoir to succeed as a salesman. The more you grow your sales reservoir, the more you keep your customers; and the more you convert prospects to customers.
I recommend the selling champion’s 10-5-5 rule to salesmen and businesspeople. It is a smart strategy to reach out to all the categories of customers.
Remember, business is about customers
No business succeeds without customers. Customers are the reason for business, and business is the reason for the customer. Without business there won’t be customers and without customers, there won’t be any business.
Customers might sometimes stop buying your product for one reason or the other. Activities of competitors might divert the customer from buying from you. According to the American Society for Quality Control, among other things, competition contributes 9 per cent to the reasons customers stop doing business with organisations. A customer that the salesman does not have a strong bond with may easily move to another brand because of an insignificant reason. Therefore, it is the duty of the salesman and his company not to allow any gap that could cause a customer’s exit.
Staff exit and transfers can also make companies to lose track of their customers. Where there are poor follow-up systems, companies often lose these customers. This is one of the challenges the 10/5/5 rule seeks to provide solution for.
There shouldn’t be a gap in managing a customer. Salesmen who are alert to their duties should know when competing brands want to gain competitive advantage in the market. Your competitor could come up with better products, services, prices and process. It takes smart sales and marketing team to decode happenings in the marketplace.
It is your duty as a marketing professional to keep your company informed. Be proactive. Issues concerning the customer should be taken seriously. No serious organisation toys with its customers.
George O. Emetuche is a Brian Tracy endorsed bestselling author, accredited training consultant, life coach, sales and marketing consultant.
– As UNILAG Faculty of Pharmacy holds maiden scientific conference
Seasoned professionals in the pharmaceutical and life sciences have saddled pharmacists in the academia with the obligation of strengthening national health systems, as well as charting a new course for pharmaceutical sciences in the country.
According to them, these can be achieved through the creation of R&D faculty plans and tailoring of teaching and training towards drug development.
The experts, who included Vice-Chancellor, University of Lagos (UNILAG), Prof. Oluwatoyin Ogundipe; Deputy Vice-Chancellor, Academics and Research, Prof. Wole Familoni; Dean, Faculty of Pharmacy, Prof. Glory Ajayi; University Liberian, Dr Yemi Zaid; and Secretary-General, West African Postgraduate College of Pharmacists (WAPCP) Prof. Noel Wannang, harped on the need to leverage technology to improve service delivery and collaboration between academia and pharmaceutical companies.
R-L: Conference Committee Chairperson, Prof. A.A. Adepoju-Bello; Dean, Faculty of Pharmacy, University of Lagos, Prof. Glory O. Ajayi; Dr C.P. Azubuike, committee member; Dr M. Sofidiya, committee vice-chairman; and Dr A. Joda, member of committee.
The specialists, who also included Prof. Adeboye Adejare, University of the Sciences, Philadelphia, USA; Prof. Olobayo Kunle, former acting DG, NIPRD; Deputy Provost, College of Medicine, University of Lagos, Prof. Osaretin Albert Ebuehi; Chief Operating Officer, Alpha Pharmacy and Chairman, Association of Industrial Pharmacists of Nigeria (NAIP), Pharm. Ignatius Anukwu, noted the negative impacts of the COVID-19 pandemic on national healthcare delivery systems and emphasising that urgent improvement is particularly imperative in the nation’s healthcare sector.
They further stressed that academic pharmacists, being key stakeholders, must rise to the challenge by engaging in politically-inclined research for advocacy, establishing cross specialities, cross-institutional/ cross-generational teams, and developing local models for herbal medicines research.
The erudite scholars converged at the recent UNILAG pharmacy faculty’s First Annual Scientific Conference held virtually, with the theme: “Post-COVID-19: Charting a course for the pharmaceutical sciences and health systems strengthening”.
In a communiqué announcing the resolutions of the two-day conference, the faculty highlighted key issues to be brought to the front burner for healthcare systems development to be a reality.
The conference acknowledged the important roles of pharmacists, especially those in the academia, urging them to face the challenges squarely by evolving practices and policies that will provide solutions.
According to the communique: “Apart from addressing the impacts of COVID-19 during this conference, hosting an annual scientific conference by the faculty will provide a forum for sharing research findings by faculty members with other scientists and pharmacist, as this will encourage collaborations.
“Conference also agreed that health systems are dependent on a sound pharmaceutical sector and the pharmaceutical industry is completely dependent on a vibrant pharmaceutical sciences subsector as typified in the public academic institutions and the research institutes.
“Conference observed that the pandemic brought some much-needed attention to the research landscape with state governments, TETFUND, CBN and multinational companies setting up committees and investing in research to look inwards to find practical solutions to the pandemic;
“Conference agreed that our mind-set must change from the silos mentality to collaborative research within the academia and the research institutes with effective collaboration with the pharmaceutical industry. Currently, there is a vast disconnect between the industry and academia.”
The document also stated that government’s involvement cannot be overemphasised in actualising the expected changes and improvements.
“While conference recognises that there are aspects of charting the course for the pharmaceutical sciences in the hands of the faculties and the local research community, government input is essential. Government input in terms of effective policies, appropriate funding, enhancing the research environment, uptake and utilisation of research outcomes is required to ensure a complete overhaul of the processes for the future”, the document stated.
The researchers were also reminded on the need to leverage technology as an enabler, and not an end in itself.
“Technology should be seen as a catalyst; so if the system is not sound, technology will make it much worse. Technology will help add value to a system that is good but will not make a bad system better,” they noted.
The conference also called for continuous advocacy with the government at all levels in promoting and achieving public health services by pharmacists.
“A concise policy or regulation on vaccination that includes pharmacists is long overdue, and conference calls on
Ever since the World Health Organisation approved the vaccines for COVID-19, producing nations seem to have charted a course for themselves in history as perhaps the most significant stakeholders in the fight against the noisome pestilence. From India’s AstraZeneca to America’s Pfizer, there is a palpable sense of national pride that comes with these vaccines.
To some observers, however, this sense of pride is gradually transmuting into a basis for determining the COVID-19 vaccination processes in other nations of the world. For instance, after India had exported over 66 million doses, it decided to halt further exports, as a result of the new wave of the infection which has taken catastrophic dimensions in the country. This halt is already affecting the vaccination process in countries like Nepal, Bangladesh, Sri Lanka and many countries in Africa, including Nigeria.
Some experts have warned that Africa’s failure to produce a vaccine, despite its capabilities in human and material resources, will not augur well for the continent in view of the fact that many more medical emergencies could spring up in future. According to this school of thought, this failure is never about the lack of intellectual capacity but more about the lack of political will by African governments to entrench and sustain a culture of cutting-edge drug research and development.
For Gerald Mboowa, a bioinformatics researcher at the Makerere University in Uganda and infectious disease specialist, the nature of research in Africa which is hugely dependent on foreign funding is not helping matters as it does not allow African researchers to think independently and address local issues.
According to Mboowa, “Many research facilities across Africa are funded majorly by the western countries and this means that most of the research agenda is dictated by these countries and not African countries. African researchers generate data for these funders which is then used to manufacture value-added innovations and products that again get sold back to the continent. African technological innovations are being undermined or discouraged while creating a market for western-led innovations/products.”
By their usual disposition, most African governments prefer ready-made medical solutions; they do not encourage their best brains to think locally. This disposition is the reason many heads of governments in the continent prefer to patronise foreign medical facilities while those right in their countries continue to deteriorate. In Nigeria, for instance, billions of naira are yearly budgeted for the state-house clinic and yet the president prefers to embark on medical trips to London.
According to Dr Christian Happi, a molecular biologist and genomicist who leads the African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) in Nigeria, “In the process of this pandemic, did people make an effort to make vaccines in Africa? The reality is, yes they did. But were those vaccine candidates supported? The answer is no. Africa didn’t invest in Covid19 vaccine development when we could have produced a vaccine for the African population.”
Happi also corroborated the view that Africa’s failure to produce a vaccine may not be unconnected to the colonisation legacy that upholds the misconception that anything from the Western nations is the best.
“We have the human resources, we have the know-how; we have the intellectual capacity, but we don’t have the political will to mobilise the resources to make it happen”, Happi said, adding that the preference to buy imported vaccines rather than develop and produce them is a legacy of colonization.
Already India’s suspension of the AstraZeneca vaccine is causing tension in many countries, including Nigeria which had received 4 million doses in March. The problem is that those who had received their first jabs may not be able to receive the second for now, going by the current situation in India. This scenario has led to a couple of contingency arrangements, as evidenced by NAFDAC’s approval of both the Pfizer and Johnson and Johnson brands.
Many have also argued that Nigeria and other African countries could have avoided the precarious situation they have found themselves in if they had been more futuristic in their handling of health-related issues and infrastructure. There are those who also think that the so-called vaccine world powers are deliberately making export difficult to further expose the weakness of Africa’s health systems.
It is shameful that some oil-producing countries in Africa don’t even have functional refineries. They prefer to export crude oil and have them refined overseas only to import the same product. The same way they have deliberately refused to fix the refinery is the way they are deliberately killing the health infrastructures in their countries because they can afford to travel to the developed countries of the world to seek medical attention.
African leaders must take pragmatic steps towards decolonising their mindsets and reengineering their worldviews; otherwise, the continent will continue to be a slave to the developed world.
Master Horace Alichukwu, a Senior Secondary 1 student of the Government Science Technical College (GSTC), Kwali, FCT, has appealed to Nigerians for financial support to undergo a surgery to remove fluid from his eye.
Alichukwu, made the appeal in an interview with the News Agency of Nigeria (NAN) in Abuja on Monday.
He said that the surgical procedure was urgently needed so that he does not go blind.
”I call on the federal government and Non-Governmental Organisations (NGOs) as well as philanthropists to help me with financial support for the surgery.
”I was injured by a senior student who mistakenly hit my left eye with a belt on May 26 in school. I want to go back to school and study.
”My parents took me to see a doctor in Kaduna and he advised them to allow me have a surgery to save my left eye.
Also speaking, Onyinye, mother of the student, begged Nigerians to come to her son’s aid and save his eye.
”I have spent all my savings on my son without any solution so far. I appeal to kindhearted Nigerians to come to my son’s rescue.
”The doctor said he needs a surgery that involves the removal and replacement of some or all of the fluid in the eye.
”The procedure is called ‘Vitrectomy’, and the doctor said the surgical procedure to be carried out is for the purpose of eliminating permanent vision loss,” she said. (NAN)
A Coalition of NGOs, “State of Emergency GBV Movement”, has decried the rise in cases of Sexual and Gender-Based Violence (SGBV) in Nigeria.
A statement issued by Chioma Agwuegbo on behalf of the group, said that Nigeria was experiencing a surge in such cases, especially at the peak of the COVID-19 pandemic.
Agwuegbo said that it was particularly worrisome because the menace of SGBV still prevailed several months after state governors declared an emergency on it.
“During the COVID-19 outbreak and the nationwide lockdown, Nigeria witnessed a disturbing surge in cases of Sexual and Gender-Based Violence. Before the pandemic, violent and domestic attacks on women were common.
“However, the lockdown caused a significant spike in the incidents, resulting in an alarming increase in brutality and death.
“According to the Nigeria Demographic and Health Survey (2018), 30 per cent of girls and women between the ages of 15 and 49 were reported being subjected to sexual abuse.
“The Lagos State Domestic and Gender Violence Response Team reported a total of 3193 cases of gender-based violence between January and December 2020 alone.
“The statistics are similarly dire across the rest of the country,” she said.
Agwuegbo recalled that the coalition was inaugurated one year ago, following the death of 22-year-old Vera Omozuwa to advocate urgent actions to prevent the scourge of SGBV.
“Today, we are here to ask our leaders who promised to take action against this scourge what has changed?
“Too many women and young girls have lost their lives to these heinous acts perpetrated by criminals, with cases either totally ignored and justice delayed indefinitely.
“The murder of 22-year-old Vera Omozuwa, who was gang-raped and clubbed to death inside the Ikpoba Hill branch of Redeemed Christian Church of God in Benin City on May 2020, is still being litigated one year after.
“Around the same time, a 12-year-old minor was raped by a 57-year-old man and many others across the country,” she said.
She said that several top government officials had been found culpable in the act.
“It is imperative to highlight that the prosecution of Kogi State Commissioner for Water Resources, Abdulmumuni Danga, accused of assaulting Elizabeth Oyeniyi in March 2020 has stalled.
“Similarly, the accusations leveled against the Ogun State Commissioner for Environment, Abiodun Abdul-Balogun of attempting to rape a 16-year-old schoolgirl on December 31, 2020, remain uninvestigated.
“Sexual harassment and physical violence are only part of the horrors Nigerian women are continually subjected to, including harmful traditional practices, psychological abuse, and acts of socio-economic violence.
“According to the World Population Review, Nigeria is the seventh most dangerous country in the world for women to live in,” she said. (NAN)
Dr Ifeoma Azubuike, Obstetrics and Gynecologist at Federal Medical Centre (FMC) Owerri, says hysterectomy is the permanent solution to fibroid.
She said this in an interview with the News Agency of Nigeria (NAN) in Abuja on Monday.
Hysterectomy is an operation to remove the uterus. The surgery may be done for different reasons, including uterine fibroids that cause pain, bleeding or other problems.
Uterine prolapse is the sliding of the uterus from its normal position into the vaginal canal.
Azubuike, therefore, explained that the only permanent treatment to fibroid was surgery, which could be myomectomy or hysterectomy, depending on the individual’s symptoms.
Hysterectomy Solution to Fibroid – Gynecologist
The medical practitioner also said that fibroid would likely occur again after myomectomy surgery but permanently treated after hysterectomy.
According to her, the main treatment is surgery, either myomectomy, bearing in mind it can occur again or hysterectomy, which is the permanent treatment.
She added that “fibroid surgery is advised based on an individual’s symptoms but usually when the symptoms become life threatening, we advise surgery.”
The gynecologist, who said that some drugs could shrink the big ones to make surgical removal easy, noted that they start to grow again once the drugs were stopped.
“They grow again at times more than before. So, the drugs are given with surgery in view. Nothing has been proven to be able to remove fibroids completely.”
The medical doctor, who said that the cause remained largely unknown, however noted some risk factors to include nulliparity, obesity, hyperestrogenic state, multiparity and smoking, saying it was more in black women.
Azubuike explained that its symptoms depended on where in the uterus it occurred and size also.
“Common symptoms are heavy menstrual period, prolonged menstrual period, intermenstrual bleeding, pain during sex, recurrent pregnancy losses, pressure symptoms when sizeable, lower abdominal pain and abdominal swelling.”
She also said that the ailment could be asymptomatic and could be managed with both drugs and surgery.
“Drugs are used for a short period or to manage particular symptoms and not to treat the fibroids,” she added. (NAN)
Pharm (Sir) Valentine Ezeiru is the chief executive officer of Oculus PharmaCare Limited. In this email interview with Pharmanews, the Fellow of the Pharmaceutical Society of Nigeria, provides in-depth perspectives on some fundamental issues affecting the Nigerian pharmaceutical landscape. A firm believer in the provision of quality healthcare products and services, he is equally an advocate of a better Nigeria where the best infrastructure and amenities are made available, especially for importers, manufacturers and all whose businesses are critical to the growth of the nation’s economy. Excerpts:
What gap is Oculus working to bridge in the Nigerian pharmaceutical landscape?
The first National Drug Policy was published in 1990. The objectives of the policy were to make available, at all times, medicines which are effective, affordable, safe and of good quality in all sectors of the healthcare system; and to improve the quality of healthcare, through the rational use of medicines. The extent to which the policy objectives have been met is yet to be evaluated.
Healthcare stakeholders and enlightened individuals recognise that some important gaps still exist. These include: poor quality of some pharmaceuticals, lack of ready accessibility to available pharmaceuticals, high prices of imported pharmaceuticals, high taxes on essential medicines, no national standard treatment guidelines, absence of well-structured drug information services, little or no public education on rational use of drugs, among others.
Pharm (Sir) Valentine Ezeiru
These gaps needed to be bridged and Oculus PharmaCare Limited was actually set up to address the variances. Oculus has, in fact, done its best these past 20 years and is still working to bridge the gaps as captured by its vision.
What is the vision guiding the company?
Our vision in Oculus is to be a highly professional and innovative company, providing high quality healthcare products and first class services to Nigerian patients through our various partners and associates, while satisfying the interest of all stakeholders.
Over the years this vision has been upheld and anything that does not reflect supply of top quality products or support the delivery of first class services, we do not get involved in it.
I am pleased to announce that Oculus is now a well-trusted and highly respected healthcare company, with the well-being and safety of all patients at the heart of the business. Our principal activity is marketing and distribution of pharmaceuticals and allied products.
Every day, we strive to provide quality healthcare products and first class services to our various partners, helping millions of people who use our products and services to be well and stay well.
We are a company guided by a set of core values which make us unique. We are passionate about doing what is right for our customers, colleagues, shareholders and communities and, by doing so, we can better serve the health and well-being of people. We strive to be creative, proactive, using innovative ways to attain our goals.
We are making giant strides in the industry with a new subsidiary of Oculus PharmaCare, NOMEDI Pharmaceuticals Limited. NOMEDI is primarily engaged in the importation and distribution of pharmaceuticals, neutraceuticals and medical devices.
How would you describe businesses in the Nigerian pharmaceutical industry?
The Nigerian pharmaceutical industry is an import-dependent one. Businesses in the industry are largely characterised by wholesale importation of finished products, as well as retail pharmacy business.
This scenario comes with its attendant challenges. These challenges have prompted public and political interests in considering local production of pharmaceuticals, with the aim of promoting self-sufficiency, achieving independence from international suppliers, developing local industrial capacity, producing foreign exchange through exportation of domestically manufactured medicines and creating new jobs.
Of recent, there has been a parallel increase in the number of companies involved in local drug manufacturing. However, the import-dependent ones still flourish more than the due to a number of factors and constraints.
What do you consider the toughest challenge facing you as a company here in Nigeria?
There are indeed so many challenges facing us as a company operating in Nigeria. As importers of pharmaceutical products, the toughest is the forex crisis – lack of access to foreign exchange to buy and pay our partners. The paucity of forex is gradually grinding operations in drug manufacturing and importation to a halt.
The second aspect is low financing in the industry. The banks’ interest rate is at an all time high – at about 22 per cent. Operating at such a cost will result in high and uncompetitive pricing, in the face of rising inflation and the populace becoming extremely price sensitive.
The third factor is the declining economy and the gradual lowering of the purchasing power of the populace, occasioned by increase in inflationary rate. These developments are further barriers to the challenge of making high quality and affordable medicines available to a majority of our people. They have also encouraged the embrace of cheap but substandard medicines by our people, with the attendant negative effects on our national growth and development
How has the COVID-19 experience affected your business?
I want to say that the COVID-19 pandemic is real. It has seriously impacted our business. There are many bad sides to the impact and at the same time, we have learnt some lessons that are indeed helping us to keep the business afloat.
*Some of the challenges we have encountered include:
*Massive disruptions in global supply chains and Nigeria is particularly vulnerable because nearly 75 per cent of its drug supply is imported from Europe, China and India.
*Some of our products handled under our subsidiary company were affected because of scarcity of APIs; many other pharmaceutical companies are worse hit in this regard.
*Significant pressure on sales performance, due to reduced demand. The purchasing power of the populace/household income is dwindling.
*Reduced cash inflows and liquidity challenges, due to significant downward pressure on demand.
*Reduced profit levels, as the margins were crashed to make prices of products more competitive. This has affected the achievement of the targeted profitable growth.
*High receivables due to increased credit risk defaults and lower recoveries, especially from supplies to government institutions.
*Customer interaction has been sub-optimal because of the safety protocol measures instituted to curtail the spread of COVID-19. We have deliberately shifted interaction from face-to-face engagement to digital platforms and virtual meetings, which have their challenges.
On the other hand, the lessons learnt have helped to plan strategically – for instance, in situations where we place all our orders of one year with our manufacturers, at the beginning of the year. As a result of this anticipatory action, our major business portfolio is supported by a solid supply chain and enhanced by good stock planning and effective inventory management.
In all our operations, we have carefully and consistently maintained safety and hygiene protocol measures. Safety measures are still in place and being reinforced. Most of our meetings in the offices and the ones with the field force members in the major cities of the country are being organised and conducted virtually.
Do you share the view that government is not doing enough to enhance the ease of doing business in the country?
The ease of doing business refers to the conduciveness of the regulatory environment to the starting and operation of a local firm. This is very important because the growth of businesses in any economy provides support to government in addressing and overcoming economic challenges faced by the society like job creation, financial resources generation and in improving the standard of living of the citizens.
Nigeria improved in ranking on the latest World Bank’s ease of doing business index, rankeding 131 in the Year 2020 Index and then moved 15 places from the 2019 Index. It was a welcome development.
Even though the government has been making efforts in recent times to improve, much more still needs to be done, especially in the area of deficient infrastructure, erratic power supply, foreign exchange shortages, high inflation, currency volatility, corruption, high capital cost, red tape, as well as excessive and unpredictable regulations.
How would you assess the role of Pharmacists in the fight against Covid-19?
As healthcare professionals, Pharmacists have been playing key role in the fight against Covid-19. At all levels, whether Hospital Pharmacy, Community Practice or Industry, they have been involved in providing pharmaceutical care to Covid-19 patients.
They also provide reliable information for preventing, detecting, treating and managing coronavirus infections. They have been committed to ensuring that the population has access to healthcare services and to minimize the adverse impact of the pandemic. This is quite commendable!
If you were to advise the Nigerian government on pharmaceutical issues, what would you tell them?
My advice to the government is that they should do more in providing infrastructural framework to check illegal importation, manufacture and sale of fake, adulterated and substandard products, due to dishonest drug dealers and some corrupt government officials. The recent 100 per cent check of containers, has no doubt, helped in greatly reducing and discouraging the importation of fake, adulterated and substandard expired goods through the ports of entry.
Government should tackle the forex crisis, as urgently as possible and help provide greater access to foreign exchange for sourcing of imported raw material and finished pharmaceutical products.
In other to enable local pharmaceutical companies in Nigeria to thrive and compete favourably with those in developed countries of the world, the government must play an active role in infrastructural development, stable power supply, stable policies, security of lives and property, creating an enabling environment, as well as developing the money and capital market for easy access to medium and long term funds.
Lastly, there is an urgent need to attract foreign direct investment, if we want our economy to grow robustly. For this to happen, it is the responsibility of government to provide the appropriate policy frameworks, institutional structures, legal frameworks and apposite regulatory environments.
I sincerely believe that if the government employs the political will to discharge this responsibility, our economy will be the better for it and the pharmaceutical issues would be positively addressed.
Authorities in 92 countries shut down 113,000 websites and online marketplaces selling counterfeit or illicit medicines and medical products last month, including vast quantities of fake COVID19 tests and face masks, the International Criminal Police Organisation, commonly known as INTERPOL said on Tuesday.
“As the pandemic forced more people to move their lives online, criminals were quick to target these new ‘customers’,” Jurgen Stock, secretary-general of the international police agency, said in a statement.
Unauthorised COVID-19 testing kits accounted for over half of all the medical devices seized from May 18 to 25, the agency said, while Italian authorities found more than 500,000 fake surgical masks and 35 machines for their production and packaging.
Police arrested 227 people worldwide and recovered pharmaceutical products worth $23 million.
“Whilst some individuals were knowingly buying illicit medicines, many thousands of victims were unwittingly putting their health and potentially their lives at risk,” Stock said.
Fake and illicit drugs were also found concealed in shipments of clothes, jewellery, toys and food.
The roughly nine million devices and drugs seized was the highest number since INTERPOL began coordinating the fake medicine campaigns, known as Pangea operations, in 2008.
At the Sesan Kareem Institute, we frequently emphasise why emotional intelligence is critical for leadership success. Whether you’re a business leader, political leader, spiritual leader or a leader at your home, improving your emotional vocabulary, awareness, and understanding will help you to succeed in your leadership roles.
By the way, we are all leaders in our individual spheres of influence. Leading people comes with responsibility and authority. It is a tough job to influence different people with different personalities and emotional wavelengths. However, great leaders are people-oriented; they are those who have mastered the science and art of getting the best from their team members.
In our COVID-19-ravaged world, leaders require a high dose of emotional mastery during these tough times to navigate challenges and create new opportunities for their people. Therefore, leaders who desire to succeed must first master their own emotions and manage other people’s emotions effectively.
Pharm. Sesan Kareem
Why leaders need emotional intelligence
There are five critical reasons why emotional mastery is essential for leaders. In this edition we will discuss the first two reasons.
Wellbeing
The first reason while leaders must improve their emotional stability during these difficult times is because emotions affect the wellbeing of the leader and the entire workforce. Let’s face it. Over the last 12 months, we’ve experienced a lot of unpleasant feelings – from stress, anxiety, boredom, frustration to worry, fear, anger and loneliness. What studies have shown us is that for both adults and children, when we experience a lot of consistent, unpleasant emotions, we go into survival mode. We initiate a flight, fight or freeze response.
As a matter of truth, the part of our brains responsible for good feelings literally get cut off when we are experiencing high levels of stress. However, moderate levels of stress are acceptable, even necessary. For instance, the stress associated with learning a new thing is a moderate stress and is a good one. Unfortunately, what we are discussing here is the bad stress.
As a leader, many of your workers are already worried, frustrated and overwhelmed with the socio-economic impact of the pandemic and it may look like they have attention problem. The truth however may be that they’ve had so much stress that hasn’t been managed effectively and it’s manifesting itself in their wellbeing.
Pleasant emotions are generally very helpful for wellbeing. For example, when we experience calmness, serenity and inspiration, the parts of our brain responsible for thriving light up. Thus, the bottom-line includes: one, we have to manage stress effectively (our own and our team members); two, we have to create a work environment where people feel a sense of safety and trust, as well as ownership and togetherness. This isn’t easy to create and maintain. But we must try as leaders. Three, we have to create as many opportunities as possible for ourselves and for our employees to experience the calmness, serenity and inspiration essential for optimum wellbeing.
Relationships
The second reason emotional intelligence matters for leaders is that they affect the quality of our relationships. At the Sesan Kareem Institute, I often discuss emotions as signals to engage or disengage. This occurs for our own experience of emotion. There are days you wake up and you feel, “I want to meet everybody I can talk to today.” Other days, you wake up and feel frustrated or stressed and you’re like, “I don’t really like to talk to anyone today.” However, as a leader, you must not allow your feelings to dictate your actions.
What is fascinating about emotions is that we’re observing the world around us every day. We are noticing our team members’ body language, voices, vocal tones and facial expressions. What studies have shown us is that individuals who display a lot of unpleasant emotions are sending signals not to engage. On the flip side, those who display pleasant emotions are sending positive signals for people to engage them.
When it comes to our team members they may be displaying a lot of unpleasant emotions because of the tough times the world has been in. They may feel anxious, stressed, frustrated or act inappropriately. My hope is that you will see that as a signal to engage. Because what is beneath that behaviour is a need that is not met. To get the best out of your team you must engage them even at their lowest point.
In conclusion, I would like to offer you a simple exercise. Over the next few days, take a moment and just think about the different people that you work with. Write their names down, and just jot down the first feeling that comes to mind around that person. Ask yourself, does that feeling influence the way I approach that person, the way I engage that person, the way I greet that person, the way I listen to that person?
What this exercise can do is to improve your self-awareness about the quality of your relationships.
Action plan: Strive to intentionally slow down to be more conscious about how you feel each moment. Also, be conscious about the signals other people are sending to you when they disengage or engage.
Affirmation: I master my emotion. I am blessed and highly favoured.
Sesan Kareem serves as Regional Manager at Pharmaplus, www.pharmaplus.com. ng, and the Principal Consultant at Sesan Kareem Institute, www. sesankareem.com.ng
Dr Chinonso Egemba, a medical doctor popularly known as Aproko Doctor on social media platforms has warned against replacing water with slimming tea in order to shed pounds.
He narrated a story of a woman that was rushed to the hospital with a very low blood pressure and how the doctor informed her that the cause of the condition was because she had lost so much fluid in her body.
According to the woman, she has been taking a lot of slimming tea and for her that has replaced water.
The Centers for Disease Control and Prevention (CDC) also highlights the importance of water for preventing dehydration.
Dehydration can cause problems that include changes in mood, difficulty thinking, and other physical complications. Drinking a glass of hot lemon water before bed is a good way to stay hydrated.
According to medicalnewstoday most health claims for additional hydration lack evidence. For instance, they found limited evidence to support the statement that hydration could improve thinking skills, reducing kidney stone risk, or support weight loss.
Egemba explained that what people go through because they need to keep excess weight off could be alarming, noting that there are claims of people being sold tapeworm eggs as slimming pills.
He also gave tips on how to eat the foods you love while kicking off the weight, adding that losing weight can seem overwhelming yet one have to figure out how to eat healthily and fuel your body properly.
He advised that people should plan exercise regimen that works for them, get plenty of sleep, and ultimately make hundreds of choices each day that will either bring them closer to their goal or throw them completely off track.
Katie Cavuto MS, RD, the dietitian for the Philadelphia Phillies and Flyers, also suggested that keeping washed and prepared veggies like cucumbers, peppers, sugar snap peas, and carrots inside the fridge is also another way to lose weight.
She said since bananas, apples, pears, and oranges are good fruits, they should be kept on the counter where they can be easily accessible to people.
We are pleased to inform our distinguished readers and friends that Pharmanews has been nominated again for the Nigerian Healthcare Media Excellence Award-Print, and electronic voting has commenced, but it will end by 12 midnight of Wednesday 23 June 2021.
It will be recalled that Pharmanews was nominated in 2017, 2018 and 2019 for the same award, and through your generous voting, we emerged winner of the category.
This year, we are at it again, as Pharmanews has appeared among the over 100 nominees for the 7th edition of the Nigerian Healthcare Excellence Awards (NHEA), which will take place on Friday, 25 June 2021, at the Eko Hotels & Suites, Victoria Island, Lagos.
For easy identification of Pharmanews on the voting platform, you will find the category tagged: Special Awards – Healthcare Media Excellence Award-Print.
We hereby solicit your VOTE, within the very limited time to win again. Kindly note that for your vote to count, you need to follow the steps listed below. Click the link below to vote.
Dr Nonye Onyewuenyi, a pharmaceutical chemist, with over 15 years’ experience within the pharmaceutical and radiopharmaceutical industries, is an associate director and global programme technical project leader at Sandoz-Novartis (New Jersey, US), with expertise in drug product development. In this e-mail interview with TEMITOPE OBAYENDO, she discusses solutions to the perennial problem of substandard and counterfeit drugs in Nigeria, saying there are more than 40 technologies worldwide that can aid in the detection of falsified drugs. She also dissects other key issues in the pharmaceutical industry that require attention, such as high rates of employees turnover and capacity building. Excerpts:
Please, tell us a little about yourself.
My career and life experiences span across what I call the global north and global south, which include the United States, Australia and Nigeria, among others. I have over 15 years of experience within the pharmaceutical and radiopharmaceutical industries, including Australian Nuclear Science & Technology Organisation (ANSTO), Johnson & Johnson, Mallinckrodt Pharmaceuticals, and for the last four-and-a- half years, Sandoz-Novartis.
I have worked with brand and generic organisations for the development of new drugs, both small drug-like molecules and larger protein biologics. Pre-formulation activities, including method development and validation and design of enabled controlled-/ modified release formulations for complex drug products with enhanced bioavailability, were critical for successful submissions with the US FDA of both New Drug Applications (NDA) and Abbreviated NDAs (ANDA) drug products.
I obtained my BSc, MSc and PhD in Chemistry from the University of New South Wales, Sydney, Australia. I also obtained B.Sc. Ed (Chemistry) from Ahmadu Bello University (ABU) Zaria and Masters in Personnel Management from the University of Lagos. I was granted adjunct professorship (on hold) at the New Jersey Institute of Technology, Newark, USA, and University of Missouri, School of Pharmacy (UMKC), USA, for graduate students.
Dr Nonye Onyewuenyi
I was the director, Women in Science (WIS), Healthcare Businesswomen Association (HBA), St Louis Chapter, Missouri, USA (2008-2010); board member for the Women Chemists Committee (WCC) of the American Chemical Society (2013 – 2015), and the Nigerian Association of Pharmacists & Pharmaceutical Scientists in the Americas (NAPPSA) (2011- present)
In addition, I was the general secretary for NAPPSA from 2013 to 2019. I also served as the Chair of the Women in Science in Mallinckrodt (WISIM), and have been a member of the American Association of Pharmaceutical Scientists (AAPS) since 2002.
I have over 40 publications, with patents/applications; as well as over 25 invited presentations and meeting presentations. I also co-edited a book, titled “Methodologies for Complex Modified-Release Pharmaceutical Dosage Forms”.
One of the major issues rocking the Nigerian pharmaceutical industry is circulation of fake and substandard medicines. As a quality control expert, which technologies would you recommend to curb this?
In my first experience in the pharmaceutical industry as a quality control chemist for a French-American pharmaceutical company in Sydney, Australia, I was not only charged with developing and validating robust and effective analytical methods, and training new chemists, I was responsible for ensuring that the diverse raw materials and pharmaceutical finished products (tablets, capsules, suspensions, etc.) met the specification and guidelines as provided by Australian regulatory authorities. With this background, I built and developed the skill and skill sets of applying acceptable and best-in-class techniques and technologies for analysing drug products.
According to WHO’s evaluation of six African countries in 2011, they confirmed that Nigeria came last by a long shot. As a result, Nigeria launched an impressive search and methodology for counter-offensive against fake drugs. Patrick Egwu (in “This is Africa, Politics & Society” 2017), noted that Nigeria, “…by utilising a range of technologies…” sought innovation and became one – an innovator.
However, more than 40 technologies worldwide have been identified that can aid in the detection of sub-standard and falsified drugs. These technologies range from simple checklists for evaluating packaging, to complex analytical chemistry for fingerprinting the source of a falsified drug. There are critical factors such as cost, size of organisation that must be considered before choosing appropriate technology for detecting these counterfeit and sub-standard drugs.
Different conditions and availability of funds determine technology selection criteria, e.g.
Purpose of the test: They include testing site and the purpose for testing. Factors related to the testing site include whether there is a consistent electrical supply, what level of training the staff have, and if the purpose of the testing is either screening or confirmation. There are many other handheld technologies, such as the Radio Frequency Identification (RFID) system, Black Eye, and TruScan, etc.
Regulatory authorities: For importers of drugs, regulatory bodies (e.g. NAFDAC) and others involved in pharmaceutical supply chains that would like to ensure that large batches of medicine are genuine, devices such as the CD3, Raman and NIR can be used.
For Patients and healthcare workers: To ensure that the drugs given to patients are genuine, they use technologies for visual inspection approaches such as the WHO checklist as a useful first step. However, this is not sufficient to identify falsified and substandard products.
Other technologies which include paper chromatography, PharmaCheck, and GPHF-MiniLab may be required. These technologies allow clinicians to distinguish between drug resistance and treatment failure due to the organism or treatment failure due to a falsified or substandard drug.
For these settings, cheap, highly feasible tests that require little training and supplies are essential.
National reference laboratories: Highly sensitive technologies such as DART or DESI, HPLC-MS and GC-MS, nanotechnology, gas chromatography, flame ionisation detector (FID) Anion-exchange chromatography, NMR Spectroscopy, etc. are best suited for national reference laboratories for confirmation testing of field-identified falsified and substandard drugs.
These highly sensitive technologies such as HPLC-MS, NMR Spectroscopy, Capillary Electrophoresis, CE-MS, etc. can be a major initiative for the federal government of Nigeria.
It has been observed that scientists in developed climes obtain their drug development ideas from research, which is usually built upon until the manufacturing of the product. This seems not to be so in Nigeria, as there exists a wide gap between research and drug development. What is your opinion on this?
Generally, a pharmaceutical company’s vision is dependent on the area of unmet medical needs they would want to focus on, as well as if they want to play in the generic market or innovator (brand). As I stated earlier, success in initiating pharmaceutical development has to be encouraged from three main initiatives – academic, government and the private sectors.
In my personal experience, and from my perspective, collaboration between the universities and the industry helps in initiating reasonable and profitable research. This was exemplified during my undergraduate studies at the University of New South Wales, Sydney, Australia, where one of my early student projects was to develop a methodology and project plan entailing how to determine oxalates in urine. This analysis of oxalates in urine not only spiked my heightened interest in the medical area/medicine, it launched me into being recruited to work in the pharmaceutical industry.
Another collaboration with a major instrumentation organisation, Agilent Technologies, created a research opportunity for the industry in collaboration with the university. In this research, I undertook a lot of synthesis of sensitive polymers, and ultimately developed optical sensors for the determination of heavy metals, both in environmental and biological samples. The instrumentation was used for preliminary screening of the interactions between the chelating agents and the heavy metals of interest.
Furthermore, this created a Nuclear Magnetic Resonance (NMR) research opportunity in my doctoral work. The NMR was used in the characterisation of the different polymers, sensitive polymers (chelated), including biological members, such as mutton membranes. These works (in different chapters of my doctoral thesis) created opportunities for both the university and the industry.
As a designer of different drug designs and formulations, which designs would you advocate for drug manufacturers in Nigeria?
From my perspective, it would be highly desirable for the pharmaceutical companies to engage in the development of drugs that address diseases that mainly affect developing countries (Nigeria inclusive); infectious and parasitic diseases. These diseases continue to threaten the health of millions of people throughout the world, with the major burden being in developing countries.
These include drugs for neglected diseases, such as kinetoplastid infections of human African trypanosomiasis (HAT), also called, African sleeping sickness, etc.
As a good team player, who has successfully worked with various teams, what are your advice on stemming the gross turnover rates of staff in pharmaceutical industry in Nigeria?
Among other defined and well documented tips to stem gross turnover rates, including hiring the right employees, pharmaceutical industries in Nigeria can utilise and implement the following:
Cultivate and demonstrate a respectful work environment. This is even more prominent or evident in our culture back home where respect is engrained in each tribal culture. Lack of respect is one of the key factors in employee turnover. Endeavour not to discount respect when it comes to creating a magnetic and inclusive culture. Always look for ways to cultivate and nurture respect in the pharma industry.
An inclusive environment/vision is one of the key factors in employee engagement and happiness. Offer employees in their work environment a strong sense of belonging and loyalty to your organisation. This increases employees’ sense of purpose and meaning in whatever they do at work
Clean up performance reviews, as this offers a prime opportunity for a big win to increase trust and fortify the company relationship with employees.
Keep compensation and benefits current, paying employees the fair going wage for their work (or better still), offer them competitive benefits.
Offer flexibility because today’s employees crave a flexible life/work balance. If all resources and necessary technologies are available, e.g. constant power supply, etc. every necessary tool and technique can become a constant to support the paradigm shift needed to create flexible work-life balance. Aligning the Nigerian petrochemical industry to all aspects of development in Nigeria will make a huge difference.
Recognise and reward employees. Show employees that they are valued and appreciated by offering them real-time recognition that celebrates their successes and their efforts.
Pay attention to, and build a culture of engagement in your company all year long.
Encourage pro-social behaviour in your employees. In other words, encourage a sense of generosity and gratitude in the employees. This gives the employees opportunity to connect with one another through acts of generosity and the expression of gratitude, thereby creating employees that will be healthier and happier, with a sense of ownership of the company
The global pandemic has introduced new normal operations in different fields. How has it affected you as a pharmaceutical scientist?
To me, as a pharmaceutical scientist and a programme/project manager in a major pharmaceutical company, the pandemic affected me personally and professionally enabling me to learn more about my resilience, motivation, attitude, creative thinking and innovation to ensure the project activities and deliverables are executed and goals met.
With the potential impact on application submission delay, I had to optimise how to manage the short term (e.g. transportation of clinical study materials, etc.) and long term impacts (e.g. response from the FDA, etc.).
As the PM leading key subject matter experts (SMEs) (of different backgrounds and high academic achievements) to achieve an actionable outcome, I learnt to create comprehensive contingency plans that can help manage new and evolving risks. In addition, I honed in on my disciplined agility and upskilling to learn new collaborative approaches to lead a virtual meeting setting (using MS Team, Webex, Zoom, Skype, Retro Tool) and other collaboration tools. The agile practices have become increasingly commonplace for me and in the industry.
Drug development and manufacturing is your core area of practice, could you share with us crucial factors that enhance a successful process of drug development?
As a project leader, I know that driving a drug product to the market safely, quickly, and cheaply is the best way for a pharmaceutical company to be successful. Drug development and manufacturing process is very complex, and faces enormous challenges, including risk management during the long product-development process. And with today’s fast-paced competition, drug development requires efficiency in all aspects of business.
The identification of risks at the right stage and an effective mitigation plan are key factors for success, both financially and technically. The complex drug-development process from lab to launch includes management of several business processes, such as technical development, using Quality by Design (QbD) regulatory strategy, clinical studies, and supply chain, as well as managing people (internal project team members and external partners).
These processes are affected not only by many circumstantial factors but also by each other. Managing these processes / factors and the interaction between them is effectively driven by project management (PjM) of these strategies and/or factors.
Simply put, PjM is the management of people, activities, time, and money toward the successful completion of a stated goal. And it is highly imperative in the complex world of pharmaceutical development {with all the circumstantial factors and its needed subject matter experts (SMEs) to have a single point person responsible for ensuring that all the pieces of a project come together efficiently, effectively, and on schedule.
A single point of project contact, an experienced pharmaceutical scientist as a project manager, must be focused on making the project successful, with the awareness of the organisation’s strategic goals, ensuring the role of the following is implemented in the project, viz. role of the project manager (PM), stakeholders, team communication, and business processes.
World Hypertension Day, 7 May, is a day designated and initiated by the World Hypertension League, an umbrella organisation of 85 national hypertension societies and leagues. The day was initiated to increase the awareness of hypertension. The theme of this year’s World Hypertension Day is “Measure your blood pressure accurately, control it, live longer.”
Hypertension, also called high blood pressure, is the increase of arterial blood pressure in the body. The normal blood pressure measurement is less than or equal to 120/80 in persons under 50 or 140/90 in persons over 50 years of age.
Chima Ejimofor
Symptoms of persistent high blood pressure
headaches
insomnia, heart problems
kidney problems, difficulty in breathing, noise in the ears
cloudy sight, frequent haemorrhages in the nose and eyes.
Nevertheless, high blood pressure may exist without symptoms. This is the reason it has been given the name, “the silent killer”.
Causes of hypertension
Hypertension could have physical or psychological causes.
Physical causes are, in general, due to the presence of atherosclerosis or arteriosclerosis or kidney problems (infection) as well as the obstruction of an artery.
Other associated causes are: Heredity, obesity, the intake of too much salt (since sodium causes a retention of liquids), smoking, drinking wine, coffee or tea in excess and use of contraceptives.
Causes with psychological origins are accompanied by current anguish, nervousness and emotional imbalances. Stress or tension causes the veins to contract, becoming smaller. This provokes an increase in pressure (this is the reason why we become pale when we are scared). People with a high stress level should make a change in their way of life, eliminate worries and nervousness, change their nutrition and exercise daily.
Suggested treatment
Eliminate salt from your meals and the use of carbohydrates and other salts as well.
It is convenient to increase the intake of potassium, calcium and vitamin D since this will cause the body to dissolve the sodium content in the body.
The intake of vitamins C, A and E, as well as exercising daily are important.
Garlic is very beneficial, either naturally or in odourless capsules.
Lecithin is also an essential element that dissolves blood clots in the veins, emulsifies fats and cholesterol, and then takes these fats to the liver for transformation.
Necessary caution
High blood pressure is a silent killer, since its presence does not produce unpleasant symptoms in the beginning. Nevertheless when the pressure increases and is constant, it starts to damage organs like the heart by making it work excessively.
The following is daily suggested for adult use:
Garlic and lecithin
Improves circulation, strengthens capillary walls, prevents and dissolves blood clots.
Omega 3
Contains polyunsaturated fatty acids, EPAa, GLA.
Omega 6,9
Improves circulation, prevents and dissolves blood clots.
These vitamins and minerals are also to be taken daily with meals:
Vitamins: A,C,D and E.
Minerals: Calcium, Magnesium, Selenium, Zinc and Germanium.
References:
Guide to Natural Remedies for Health and Well-Being – Enrique Garza Gutierrez
Google
About the Author
Mrs. Chima Ejimofor is the Lead Partner of Infinite Health Consult, and is available for the purchase of these nutritional supplements, health talks and wellness seminar. She is based in Lagos, Nigeria. Telephone/WhatsApp: 07033179632, email: infinitehealthconsult@gmail.com
There are habits, lifestyles and desires that manifest in the old or natural life. These habits wear off as you become spiritually transformed. Your friends, neighbours, relations and associates should be able to notice the change. This change is an evidence of spiritual transformation which starts one moment then the effects grow with time.
Romans 12:2 says, “And be not conformed to this world: but be ye transformed by the renewing of your mind, that ye may prove what is that good, and acceptable, and perfect, will of God.” By the power of the Holy Spirit, we are progressively transformed to right by knowing and doing the will of God. Renewing of the mind is a continuous process. The soul, which controls the mind, will and emotions steadily comes under the control and power of the Holy Spirit.
I didn’t know about pornography until the late seventies when I started travelling to advanced countries for international conferences. I discovered that nearly every country had “red districts” or “red zones” or commercial sex markets. I indulged in visiting these places. They are popular spots in big cities like London, Hamburg, Boston, Las Vegas, Paris, Amsterdam, Milan, Madrid and so on. At that time, I didn’t know there was something wrong with visiting those places, except that I had to spend my foreign exchange. In fact, visiting those places became my incentive for travelling for conferences.
Pharm.(Sir) Ifeanyi Atueyi
As one can imagine, at that time, I was a nominal Christian, a mere church-goer. How could one have been attending church without a Bible? I attended regularly because I had some friends as members and it was an opportunity of meeting them.
My commitment to church attendance was tested when I started the business of Pharmanews in 1979. I had to be directly involved in all the aspects of the business. I thought then that I could achieve a lot by working on Sunday mornings. At that time, my wife would go to church with our young kids while I remained indoors to read, write and edit manuscripts.
Honestly, I didn’t feel guilty for not going to church, except that my wife felt incomplete without me. One Sunday she returned from church and complained that she was embarrassed by one of her friends who asked her whether the young man beside her was her husband. On Sundays that I didn’t feel like working, I would go to church.
This habit of not being committed to church actually started while I was in the University of Ife, Ibadan branch. In the campus, I worshipped in the chapel occasionally. Of course, in my secondary school which was a mission school, regular attendance was compulsory.
I have realised that if God has given you an assignment, He ensures that there is a performance. He makes the necessary provisions for the assignment to be carried out successfully. During the first ten years of Pharmanews, I enjoyed prosperity. It was during this period that God equipped me with various training programmes.
The World Health Organisation (WHO) invited me to a most beneficial training for health editors in Copenhagen, Denmark in 1984. This was the training that exposed me to editors of reputable international biomedical journals. At the same seminar, I was introduced to the European Association of Science Editors (EASE) and I started attending their annual conferences and seminars in various European countries. Of course, from 1977 I started attending annual FIP conferences. I really enjoyed the favour of God and man even though I didn’t know Him as my heavenly Father.
It was after I accepted Jesus Christ as my Lord and Saviour on 11 February, 1989, that certain desires and habits changed. I realised that my life was incomplete, despite the apparent prosperity. There was a vacuum waiting to be filled. In fact, my motive for work changed. I perceived that God has a purpose for my life and specific assignments for me. It dawned on me that my work is a service unto God. I challenged myself on the use of the money, time, talents and other resources God has placed at my disposal. I even realised that I don’t even own any business as such. I am just a steward taking care of God’s business.
One habit I developed is asking God what He wants me to do and to keep me away from doing things that I should not be doing. Psalm 119:37 says it well: “Turn me away from wanting any other plan than yours…”
I first got to know Pharm. Ifeanyi Atueyi at close quarters in 1987, when he was the national secretary of the PSN. During the Annual National Conference of the PSN, which took place at the then Shukura Hotel, Sokoto, in November 1987, he virtually saved the conference from becoming a failure. I was in attendance at the conference. The issue, if I can recall had to do with the conferment of Fellowship, which unfortunately had always been a hard nut to crack by every leadership of the PSN.
When I had the honour and privilege of serving as the registrar of the Pharmacists Council of Nigeria (PCN) from 2003 to 2012, we became closer. Immediately upon my appointment, I started the lecture series in honour of the late Dr Fred B. Adenika on the death anniversary of the latter, who had served as the chairman of the Governing Council of the PCN from December, 1999 to December, 2002, and who had died on 20 February, 2003 in faraway USA.
I was a member of the PCN Governing Council as one of the eight representatives of the PSN when the late Dr Adenika was chairman of the PCN. Pharm. Atueyi delivered the first lecture on 20 February, 2004 at the head office and registry of the PCN in Idu, Abuja. He followed up with management training as capacity building programme for senior and management staff of the PCN.
The series of lectures and management trainings that followed in honour of the late chairman of the PCN became one of the highly celebrated events in the calendar of activities of the PCN for the eight years that I served as the registrar. It was during the 2008 edition of the lecture, which had as the chairperson, Dr (Mrs) Stella Okoli, MON, the General Managing Director of Emzor Pharmaceutical Ltd, Lagos, that she threw a challenge to the PCN that a book on the late former chairman of the PCN should be written. Prof. ‘Fola Tayo was the keynote speaker for that year. That was how Pharm. Atueyi and myself started a series of meetings and telephone calls and planning for the collation of materials for the publication of the book.
It was while lodging at Sheraton Hotel in downtown Atlanta, USA, during the 2008 Annual Scientific Conference and Exposition by the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) which both of us attended, that we had enough time to further articulate the draft of the book at length.
On 20 February, 2009,the book: “EXCELLENCE IN PHARMACY PRACTICE IN NIGERIA – THE FRED ADENIKA LEGACY” was presented to the public and launched at the Nigerian Institute of International Affairs, Victoria Island, Lagos. Prof. Udeala of the University of Nigeria, Nsukka (UNN) and the first pharmacist to be appointed vice-chancellor in any Nigerian university, was the book reviewer. Ifeanyi Atueyi and I had earlier both travelled together in the same car to Akure, the capital of Ondo State, the home state of the late Dr Adenika to invite the then Governor of the State, the late Dr Olusegun Agagu, to serve as the special guest of honour during the public presentation of the book.
In all these encounters with Pharm. Atueyi, I came face-to-face with a highly cerebral person whose passion for the pharmacy profession was immeasurable. I learnt a lot from him. Despite our age difference, he took me as equal, or at best a brother, with just a couple of years younger.
It was during the many interactions with Pharm. Atueyi that his (our) beloved mum died and the burial ceremony scheduled for his native Okija in Anambra State. I quickly jumped on the aircraft to Owerri in Imo State and by road to Okija to give Mama a final goodbye. I felt I must be there to support and comfort him, for the guidance and mentoring that he unknowingly imparted to me.
That was my first trip to Okija and to this day, I remain pleased with myself that I undertook what to me looked like an ordinary attendance at a friend’s mum’s burial. My attendance, as I got to know, meant a lot to Pharm. and Mrs Atueyi. He must have informed many persons at the slightest chance that I attended the burial ceremony of the late Mama Atueyi (may her gentle soul rest in perfect peace, amen) in Okija.
I later discovered that Pharm. Atueyi and Dr Leo Egbujiobi, one-time president of NAPPSA, are indeed related. There has been tremendous amount of respect between myself and Dr Leo and the realisation of the fact that he is indeed related to Pharm. Atueyi, further drew the three of us closer.
During the public presentation and launch of the 2nd edition of my book, “THE LIZARD SHAPE MODEL OF DRUG DISTRIBUTION IN NIGERIA”, in Ikeja, Lagos in February 2018, Pharm. Atueyi was in attendance and virtually turned himself into the master of ceremony to ensure the success of the event. The words of encouragement and support to me which he stated profusely during the event will forever be indelible in my mind and I remain grateful.
This article will be incomplete if I fail to link the heading to the person. Anyone familiar with Pharm. Atueyi, will not, but immediately notice the goodness in him, the humility, the charisma, but above all, as a person who always says the truth. Any discussion with him and the truth is not emphasised, he will quickly wash his hands away and will state so unequivocally that he’ll have nothing to do with it. That is the quintessential Pharm. Atueyi.
It has been an honour, a rare privilege, being in communication with this gem of a pharmacist and may the good Lord continue to grant Pharm. Atueyi long life in excellent health, added wisdom and economic prosperity. Amen.
Finally, may the ink of “PHARMANEWS” never dry. Amen.
In the four decades since the first cases of what would come to be known as AIDS were documented, scientists have made huge strides in HIV treatment, transforming what was once a death sentence into a manageable condition.
What we still don’t have is a vaccine that would train human immune systems to ward off the infection before it ever takes root.
Here’s the state of play on some of these efforts, which experts see as the “holy grail” in the fight to eliminate a virus that 38 million people live with globally.
– Why do we need a vaccine? –
More people than ever now have access to medications called antiretroviral therapy or ART, which when taken as prescribed, keeps down the amount of virus in their body.
This keeps them healthy and unable to transmit HIV to their partners.
Beyond ART, people at high risk for infection can now get pre-exposure prophylaxis, or PrEP, a pill taken every day that reduces the risk of infection by 99 percent.
“But access to medication is not organised in every part of the world,” Hanneke Schuitemaker, global head of viral vaccine discovery at Johnson & Johnson’s Janssen Vaccines, told AFP.
Even within wealthy countries, wide socio-economic and racial disparities exist in accessing these medicines, and vaccines have historically been the most effective tools to eradicate infectious diseases.
J&J is currently carrying out two human efficacy trials for its HIV vaccine candidate, and initial results from one of them may come as early as “the end of this year,” Schuitemaker said.
– Why is it so challenging? –
Vaccines against COVID-19 were developed in record time and have shown remarkable levels of safety and efficacy, helping drive down caseloads in the countries fortunate enough to have wide access.
Many of these shots were developed using technologies that were previously being tried out on HIV – so why haven’t we had breakthroughs yet?
“The human immune system doesn’t self-cure HIV, whereas what was very clear was the human immune system was quite capable of self-curing COVID-19,” Larry Corey, principal investigator of HVTN, a global organisation funding HIV vaccine development, told AFP.
COVID-19 vaccines work by eliciting antibodies that bind to the virus’ spike protein and stop it from infecting human cells.
HIV also has spike-shaped proteins on its surface, which are the target of HIV vaccine development.
But while COVID-19 has tens of well-known variants circulating worldwide, HIV has hundreds or thousands of variants inside each infected person, William Schief, an immunologist leading the development of an mRNA HIV vaccine at Scripps Research Institute told AFP.
Because it’s a “retrovirus” it quickly incorporates itself into its host’s DNA. An effective vaccine will need to stop the infection dead in its tracks, not just reduce the amount of virus and leave the remainder to stay with the person forever.
– Where do things stand now? –
Efforts to develop a vaccine have been going on for decades but have so far all ended in failure.
Last year, a study called Uhambo that was taking place in South Africa and involved the only vaccine candidate ever shown to provide some protection against the virus frustratingly ended in failure.
J&J’s vaccine candidate is currently being trialed in 2,600 women in sub-Saharan Africa in the Imbokodo trial, which is expected to report results in the coming months.
It’s also being tested in around 3,800 men who have sex with men and transgender individuals across the US, South America and Europe in the Mosaico trial.
The J&J vaccine uses similar adenovirus technology to its COVID-19 vaccine, in other words, a genetically modified cold virus delivers genetic cargo-carrying instructions for the host to develop “mosaic immunogens” – molecules capable of inducing an immune response to a wide variety of HIV strains.
This is followed up by directly injecting synthetic proteins in later doses.
Another promising approach is to try to generate “broadly neutralising antibodies” (bnAbs) which bind to areas of the HIV that are common across its many variants.
The International AIDS Vaccine Initiative and Scripps Research recently announced results from an early-stage trial showing their mRNA vaccine candidate, developed with Moderna, stimulated the production of rare immune cells that create bnAbs.
Their strategy, explained Schief, is to use a sequence of shots to try to gradually educate antibody-producing B-cells. They also hope to train up another kind of white cell, known as T-cells, to kill any cells that still get infected despite the antibodies.
Efficacy trials are still a long way off, but he’s hopeful the mRNA technology, which turns the body’s cells into vaccine factories and has proven its worth against COVID-19, can make the difference.
L-R: PSN National Secretary, Pharm. Gbenga Falabi; NAPPSA President, Dr Anthony Ikeme; Chairman, PCN; Prof. Tijani Mora; Registar, PCN, Dr N.A.E Mohammed; and another executive of the Council.
Poised to cement and expand partnership with key institutions in Nigeria, the President, Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc, Dr Anthony Ikeme, paid courtesy visits to nine key institutions in Nigeria, introducing the association’s 10 year strategy plan and other initiatives to them.
The organisational and institutional partners visited during his trip to Nigeria are: Diaspora Unit of the Federal Ministry of Health; Food and Drug Services Department of the Federal Ministry of Health; Nigerian Diaspora Commission (NiDCOM); Nigerian Centre for Disease Control (NCDC); Pharmacists Council of Nigeria (PCN); Nigerian institute for Pharmaceutical Research and Development (NIPRD); National Agency for Food and Drug Administration and Control (NAFDAC); Pharmaceutical Society of Nigeria (PSN); NAIP and Bloom Public Health.
The PSN President, Pharm (Mazi) Sam Ohuabunwa and NAPPSA President, Dr Anthony Ikeme.
The NAPPSA President, who was graciously accompanied on the courtesy visits by the former President of PSN, Pharm. Azubike Okwor; President of Africa Health Project, Dr Ali Johnson Onoja; and NAPPSA Board Member, Gbenga Olajide, expressed the delight of the group in nurturing their partnerships with the primary purpose of expanding their reach and impacting wider audience.
He also seized the opportunity to introduce NAPPSA’S 10-Year strategy plan to each of the partner visited, while highlighting some significant milestones in NAPPSA history. Some of the strategy plan are: The launch of the NAPPSA Journal: AJPPS; The launch of the NAPPSA News Magazine: NAPPSA Digest; NAPPSA Endowment Fund; Prospect of a NAPPSA house and the positive impact that will have on Nigeria’s brand and image; Proposed NAPPSA Research Institute, among others.
L-R:NAPPSA President, Dr Anthony Ikeme; NCDC Director General, Dr Chikwe Ihekweazu, and another executive of the agency.
“With the goodwill NAPPSA has built over the years and faced with multiple opportunities for making significant impact both in the USA and Nigeria, it is clear that the most efficient way to extend our reach and take advantage of the multiple opportunities for positive impact is through collaboration and partnerships.
“Collaboration and partnerships mean that we can have access to new resources, reach beyond our primary audience and have positive influence on our partners’ programmes and initiatives. It is this understanding that informed the recent outreach efforts by the NAPPSA president”, he said.
NAPPSA President, Dr Anthony Ikeme, presenting the 10-Year Strategy Plan of NAPPSA to the Secretary, NIDCOM, Engr (Dr) Sule Yakubu Bassi, during his visit.
Ikeme highlighted major achievements of the association to include: negotiation of reasonable terms for the US Pharmacy licensure reciprocity with PCN; coordination of online registration for licensure reciprocity; organisation of workshops for deans of Nigerian Pharmacy Schools; Facilitating the implementation of the PharmD programme; Active participation in the development of PharmD curriculum in Nigeria; creation of scholarship to Pharmacy students;creation of the B2B business owners platform, and others.
Leaders of the institutions visited expressed their appreciation to the NAPPSA team and made various commitments towards the actualisation of the 10-Year strategy plan.
R-L: NAPPSA President, Dr Anthony Ikeme; NIPRD Director General, Dr Peter Adigwe and another executive of the agency.
While NAFDAC and PCN made commitments to explore the possibility of publishing articles in the maiden of the NAPPSA Journal, AJPPS, they are pledged to utilise the NAPPSA Digest for disseminating institutional updates to the Diasporan community, as well as promised to attend the 2021 NAPPSA conference in Baltimore.
NIPRD also showed interest in deepening their partnership with NAPPSA, while NAIP proposed next steps in the implementation of the MOU with NAPPSA and Bloom Public Health also invited NAPPSA to participate in a planned Nigerian Pharmacy Sector Gap Analysis Project.
Researchers from the University of Illinois at Urbana-Champaign, in United States have confirmed that eating foods rich in fiber might help delay age-related brain inflammation, which usually degenerates to memory loss.
The findings which was published in the journal Frontiers in Immunology and reported on Medical News Today, explains how fiber reduces aged-related brain inflammation by triggering the production of a short-chain fatty acid that has anti-inflammatory properties.
Combination of foods and fruits rich in fiber.
According to the American researchers: “microglia, a major type of immune cell in the brain tends to become hyperactive and chronically inflamed with age. This inflammation of the microglia is one of the main causes of memory and cognitive decline in old age”.
Thus, to arrive at their findings, the lead author, Rodney Johnson, a professor and the head of the Department of Animal Sciences at the University of Illinois at Urbana-Champaign and his team members, conducted a test, using mice.
They fed young and aging mice with diets high and low in fiber. Then, the scientists measured the mice’s blood levels of butyrate and their levels of pro-inflammatory substances in their intestines.
While stating the result of their experiment, Prof. Johnson disclosed that “The high-fiber diet elevated butyrate and other [short-chain fatty acids] in the blood both for young and old mice.”
Another benefit of fiber consumption to the brain as unveiled by the findings is that it reduces intestinal inflammation in aging mice, but young mice didn’t experience intestinal inflammation.
The takeaway from the study is that people from the age of 60 and above, should eat more foods rich in fiber to retain their cognitive ability. Below are some of the foods rich in fiber:
Over three million people are reported to have died as a result of harmful use of alcohol in 2016, a report released by the World Health Organisation (WHO) on Friday said.
According to the report, “Global status report on alcohol and health 2018,” this represents one in 20 deaths.
It said, however, generally, the harmful use of alcohol caused more than 5 per cent of the global disease burden.
Bottles of different alcoholic drinks on display.
The report also said over three quarters of these deaths were among men.
Of all deaths attributable to alcohol, 28 per cent were due to injuries, such as those from traffic crashes, self-harm and interpersonal violence.
It said 21 per cent was due to digestive disorders and 19 per cent due to cardiovascular diseases.
The remaining were due to infectious diseases, cancers, mental disorders and other health conditions.
In spite of some positive global trends in the prevalence of heavy episodic drinking and number of alcohol-related deaths since 2010, the overall burden of disease and injuries caused by the harmful use of alcohol is unacceptably high.
This is particularly in the European Region and the Region of Americas, said the report.
It added that globally an estimated 237 million men and 46 million women suffered from alcohol-use disorders.
The highest prevalence is among men and women in the European region (14.8 per cent and 3.5 per cent) and the Region of Americas (11.5 per cent and 5.1 per cent), and that alcohol-use disorders are more common in high-income countries.
The report predicted that the global consumption would increase in the next 10 years.
On the quantity of alcohol being consumed, it is estimated that the average daily consumption of people who drink alcohol is 33 grams of pure alcohol a day.
This is roughly equivalent to two glasses (each of 150 ml) of wine, a large (750 ml) bottle of beer or two shots (each of 40 ml) of spirits.
Worldwide, more than a quarter (27 per cent) of all 15–19-year-olds are current drinkers.
The report said the rates of current drinking were highest among 15–19-year-olds in Europe (44 per cent), followed by the Americas (38 per cent) and the Western Pacific (38 per cent).
School surveys indicate that, in many countries, alcohol use starts before the age of 15 with very small differences between boys and girls.
Worldwide, 45 per cent of total recorded alcohol is consumed in the form of spirits; beer is the second alcoholic beverage in terms of pure alcohol consumed (34 per cent) followed by wine (12 per cent).
The report called for the need for more countries to take action to curb the trend.
“Far too many people, their families and communities suffer the consequences of the harmful use of alcohol through violence, injuries, mental health problems and diseases like cancer and stroke.
“It’s time to step up action to prevent this serious threat to the development of healthy societies.
“We would like to see Member States implement creative solutions that will save lives, such as taxing alcohol and restricting advertising.
“We must do more to cut demand and reach the target set by governments of a 10% relative reduction in consumption of alcohol globally between 2010 and 2025,” Tedros Adhanom Ghebreyesus, Director-General of WHO, said.
Also, Vladimir Poznyak, Coordinator of WHO’s Management of Substance Abuse unit, said: “All countries can do much more to reduce the health and social costs of the harmful use of alcohol.
“Proven, cost-effective actions include increasing taxes on alcoholic drinks, bans or restrictions on alcohol advertising, and restricting the physical availability of alcohol,’’ Mr Poznyak said.
The World Health Organisation (WHO) says as the risk of a surge in COVID-19 cases increases, African countries must urgently boost critical care capacity to prevent health facilities from being overwhelmed.
The world body said this in a statement, noting that the call came as vaccine shipments to the continent grind to a near halt.
It stated that “weak observance of preventive measures, increased population movement and interaction, as well as the arrival of winter in southern Africa heightened the risk of COVID-19 resurgence in many countries.”
It added that in the last two weeks, Africa recorded a 20 per cent increase in cases compared with the previous fortnight.
Dr Tedros Adhanom Ghebreyesus
“The pandemic is trending upwards in 14 countries and in the past week alone, eight countries witnessed an abrupt rise of over 30 per cent cases.
“South Africa is reporting a sustained increase in cases, while Uganda saw a 131 per cent week-on-week rise last week, with infection clusters in schools, rising cases among health workers and isolation centres and intensive care units filling up.
“Angola and Namibia are also experiencing a resurgence in cases.
“The increase came as COVID-19 vaccine shipments continue to slow down.
“Burkina Faso this week received just 115 000 doses from the COVAX Facility, while Rwanda and Togo received around 100,000 Pfizer vaccine doses each and nearly 20 African countries have used up more than two-thirds of their doses.”
It explained that the COVAX Facility is in talks with several manufacturers, as well as with countries which have vaccinated their high-risk groups to share doses, noting that “the threat of a third wave in Africa is real and rising.”
Meanwhile, Dr Matshidiso Moeti, the WHO Regional Director for Africa, said the organisation’s priority was clear, stressing that “it is crucial that we swiftly get vaccines into the arms of Africans at high risk of falling seriously ill and dying of COVID-19.
She made the world body’s position clear during a virtual news conference on Thursday, saying that “while many countries outside Africa have now vaccinated their high-priority groups and are able to even consider vaccinating children, African countries are unable to follow up with second doses for high-risk groups.
“I’m urging countries that have reached a significant vaccination coverage to release doses and keep the most vulnerable Africans out of critical care.”
According to her, 48.6 million doses have been received and 31.4 million doses administered in 50 countries in Africa.
She said that around 2 per cent of the population had received at least one dose of the COVID-19 vaccine, while 24 per cent vaccinated globally.
“As the continent struggles with vaccine shortages, the care of critically ill COVID-19 patients is also lagging behind other parts of the world.
“While Africa has 2.9 per cent of cases globally, it accounts for 3.7 per cent of deaths,” she said.
Moeti also said that a WHO survey carried out in May found that in many African countries, crucial equipment and the health workforce required to handle severely ill COVID-19 patients fall far short of needs.
She said that of the 23 countries responding to the survey, most had fewer than one intensive care unit bed per 100000 population and would require an increase of between 2500 per cent and 3000 per cent to meet needs during a surge.
According to her, among the countries providing information on ventilators, only a third of their intensive care unit beds are equipped with mechanical ventilators.
High-income countries such as Germany, Luxemburg or the United States of America that have been able to cope with COVID-19 surges have over 25 beds per 100 000 population.
“Many African hospitals and clinics are still far from ready to cope with a huge rise in critically-ill patients.
“We must better equip our hospitals and medical staff to avert the worst effects of a runaway surge.
“Treatment is the last line of defence against this virus and we cannot let it be breached,” she said.
She explained that since the onset of the pandemic, WHO worked around the clock and in collaboration with countries to ramp up COVID-19 treatment capacity by delivering essential medical supplies as well as health worker training.
The number of oxygen concentrators, for instance, increased to over 6700 as of April 2021 compared with 2600 in April 2020, with WHO providing around 3700 of the medical equipment to countries in addition to shipping about 680 ventilators, she added.
She noted that the organisation had deployed 21 experts in COVID-19 treatment to eight countries to assist in the clinical care of critically ill patients and share expertise with national health workers.
She said that to further reinforce COVID-19 critical care services, WHO recommended that every district hospital should have a high-dependency unit, while those at the regional or provincial level have an intensive care unit and higher-level health facilities.
“All intensive care units must be adequately equipped,” she added.
Moeti spoke during a virtual press conference on Thursday. (NAN)
Men who eat plenty of fermented dairy products have a lower risk of incident coronary heart disease than men who eat less of these products, according to a new study from the University of Eastern Finland. A very high consumption of non-fermented dairy products, on the other hand, was associated with an increased risk of incident coronary heart disease.
According to the Health Organisation (WHO), over 17.9 million die from cardiovascular diseases each year, and this make up 31 per cent of all deaths worldwide.
Examples of fermented dairy products include cheese, yoghurt, quark, kefir, sour cream, butter milk, viili, and sour milk, and while the local ones include nono, maishanu and wara.
Previous studies have shown that these products have more positive effects on blood lipid profiles and on reducing the risk of heart disease than other dairy products.
The Kuopio Ischaemic Heart Disease Risk Factor Study ongoing at the University of Eastern Finland explored the associations between fermented and non-fermented dairy products with the risk of incident coronary heart disease. Approximately 2,000 men participated in the research.
The findings published in the British Journal of Nutrition assessed the dietary consumption habits of participants at the beginning of the study in 1984-1989, and they were followed up for an average of 20 years. During this follow-up, 472 men experienced an incident coronary heart disease event.
The survey participants were divided into groups on the basis of how much they ate different dairy products, and the researchers compared the groups with the highest and lowest consumption, while also taking various lifestyle and nutrition factors into consideration.
When the study participants were divided into four groups on the basis of their consumption of fermented dairy products with less than 3.5 percent fat, the risk of incident coronary heart disease was 26 percent lower in the highest consumption group compared to the lowest consumption group.
Sour milk was the most commonly used low-fat fermented dairy product. The consumption of high-fat fermented dairy products, such as cheese, was not associated with the risk of incident coronary heart disease.
However, the researchers found that a very high consumption of non-fermented dairy products was associated with an increased risk of incident coronary heart disease.
Milk was the most commonly used product in this category, and a very high consumption was defined as an average daily milk intake of 0.9 litres. Lower consumption levels were not associated with the risk.
Adjunct Professor Jyrki Virtanen from the University of Eastern Finland, said “here in Finland, people’s habits of consuming different dairy products have changed over the past decades. For instance, the consumption of milk and sour milk have declined, while many fermented dairy products, such as yoghurt, quark and cheeses, have gained in popularity.”
The latest study provides further evidence on the health benefits that fermented dairy products may have over non-fermented ones.
All the mechanisms are not understood yet, but they may be linked to compounds forming during the fermentation process.
Marcia Otto assistant professor of epidemiology, human genetics and environmental sciences at UTHealth School of Public Health, and author of the study said in a statement: “Our findings not only support, but also significantly strengthen, the growing body of evidence which suggests that dairy fat, contrary to popular belief, does not increase risk of heart disease or overall mortality in older adults.”
The University of Benin Teaching Hospital (UBTH) says there is an urgent need to address ‘Out of Stock’ (OS) syndrome in Nigerian hospitals.
The institution’s Head of Pharmacy, Dr Caroline Olumese, told the News Agency of Nigeria (NAN) in Lagos that OS was no longer acceptable in modern healthcare delivery system.
Olumese advised hospitals still experiencing OS to devise a means of eliminating it within the shortest possible time.
“We should never tell patients there are no drugs,” she said.
Dr Caroline Olumese
The chief pharmacist said that UBTH had developed a policy of 100 per cent availability of drugs.
“It is no longer permitted for any staff to tell patients to source drugs from anywhere else apart from the hospital pharmacy.
“Management came up with this policy even up to availability of soaps for people with skin problems.
“The onus lies on me (the Chief Pharmacist) to bring out the money and we buy items needed by patients,” she said.
Olumese said that UBTH under the leadership of Prof. Darlington Obaseki had come up with innovative measures to ensure that the hospital would not run out of drugs.
She noted that UBTH had three major divisions in its pharmacy department – Patient Services, Drugs Services and Special Projects.
“The departments work together to ensure continuous supply of drugs to patients.
“That is our mission and vision statement: to ensure we provide quality drugs to our patients,” the chief pharmacist said.
According to Olumese, UBTH Pharmacy Department also produces some medications.
“There are some drugs you cannot get outside which we reformulate for doctors’ use.
“We also have our own oncology pharmacy and we were able to get some companies to give us biosafety cabinet.
“One biosafety cabinet is more than two million naira, and right now we have two,” she said.
The chief pharmacist said that UBTH had also been able to reduce costs and help patients to save money by reformulating drugs instead of allowing wastage.
“There is a way we do it so that three cancer patients can use the same drug instead of buying one for each,” she said.
Olumese urged hospitals to adopt the practice so that out-of-stock syndrome would be eliminated from Nigeria’s healthcare delivery system. (NAN)
Dr Kenechukwu Igwegbe, public health physician from University College Hospital, Ibadan, has warned against leaving typhoid untreated, adding that it could cause serious intestinal damage and death.
The World Health Organisation (WHO) says there are around 5,700 cases in the United States annually, and 75 per cent of these start while traveling internationally. Globally, about 21.5 million people a year contract typhoid.
“Typhoid fever, is a life-threatening infection caused by the bacterium Salmonella Typhi. It is usually spread through contaminated food or water. Once Salmonella Typhi bacteria are eaten or drunk, they multiply and spread into the bloodstream,” WHO said
The doctor said that the infection is often passed on through contaminated food and drinking water, and it is more prevalent in places where handwashing is less frequent. Noting that it can also be passed on by carriers who do not know they carry the bacteria.
According to medicalnewstoday, the two major symptoms of typhoid are fever and rash. Typhoid fever is particularly high, gradually increasing over several days up to 104 degrees Fahrenheit, or 39 to 40 degrees Celsius.
“Untreated typhoid may cause typhoid perforation. The patients may be bleeding unknowingly from such intestinal damage. In a serious untreated case, the bowel can become perforated. This can lead to peritonitis, an infection of the tissue that lines the inside of the abdomen, which has been reported as fatal in between 5 and 62 of cases,” the expert noted.
Igwegbe said, “Typhoid perforation occurs when the organism has grown and that leads to the perforation of the intestine and when it perforates the intestine, it can cause a whole lot of damage to the system.
“This perforation in the intestine leads to the sufferer vomiting and stooling blood, which causes anaemia,” he said.
According to Bio-Medical Journal – a peer-reviewed medical site, intestinal perforation is a serious complication of typhoid fever that remains a significant surgical problem in developing countries, where it is associated with high mortality and morbidity, due to lack of clean drinking water, poor sanitation, and lack of medical facilities in remote areas and delay in hospitalisation.
“The high incidence of perforation in most developing countries has been attributed to late diagnosis and the emergence of multi-drug resistant and virulent strains of Salmonella typhi,” the medical site said.
Also, the UK’s National Health Service noted that perforation of the digestive bowel is a serious medical complication.
“This is because bacteria that live in your digestive system can move into your stomach and infect the lining of your abdomen,” the UK NHS said.
The public health practitioner explained that it is caused by the bacteria Salmonella typhi and spread through food, drinks, and drinking water that are contaminated with infected fecal matter.
“Typhoid fever can be gotten when one eats infected food or through fecal-oral transmission. Washing fruit and vegetables can spread it, if contaminated water is used”.
“If you don’t wash your hands properly after using the toilet and still use your hands to eat. Those pathogens can be gotten through this means,” he said.
Igwegbe, however, said intestine perforation can be treated by surgery.
An Oncologist, Dr Patrick Omogbohun, has advised women to regularly check their cancer status by going for a check-up and eating healthy foods.
Omogbohun, also the Medical Director of a medical centre in Ejigbo, Lagos, stated this in an interview with the News Agency of Nigeria on Wednesday.
He said women must refrain from “living in self-denial”, as such attitude had made many present cancer cases late.
Cancer is a disease in which abnormal cells divide uncontrollably and destroy body tissue, which can form in the woman’s breasts, in the cervix, which is the lowermost part of the uterus, or in the prostate, the small walnut-sized gland that produces seminal fluid.
According to the doctor, the late presentation of cancer is a huge challenge to treatment.
The oncologist, who noted that the lack of awareness on cancer of the breast and that of the cervix was another huge challenge, stressed the need for increased enlightenment and for women to know the symptoms for early detection.
He added that “one of the problems we are facing here is the late presentation of cancer cases to the hospital, be it cancer of the breast or the cervix. Another thing is that women are not conscious of their breasts.
“Knowing your health status will help you to manage it, especially when there is a problem.
“The best way to tackle the disease is early detection through check-ups, such as the mammogram, sonogram, and pap smear.
“Early detection increases the chance of survival and preserves lives.”
He then recommended the use of a device called Sensor Pad for breast self-examination.
According to him, the sensor pad helps in the early detection of lumps.
He explained that “the device is to assist a woman during breast self-examination and to be familiar with her breasts.”
Quoting the latest WHO data, Omogbohun said that “every day in Nigeria, 32 women die of breast cancer, 28 women die of cervical cancer, 16 men die of prostate cancer, and 14 die of liver cancer.”
He emphasised that creating awareness and early detection through regular screening were key to survival.
Omogbohun advised that women should examine their breasts once a month and three days after their menstrual
No fewer than 391 illegal medicine premises have been shut down by the Pharmacists Council of Nigeria (PCN) in Enugu State, due to lack of compliance with the agency’s regulatory provisions for practice and operation in the country.
The regulatory body further disclosed that six compliance directives were issued to other premises for poor hygiene and other related offences.
The PCN Registrar, Dr N.A.E. Mohammed, gave the breakdown of the 391 affected premises as 90 pharmacies and 301 patent medicine stores, for failure to comply with the operational guidelines of the Council.
He said reason for the sealing of the premises is to enforce compliance with the agency’s regulatory provisions in practice and operation and also to ensure a safe and sanitized pharmaceutical environment in the nation.
Mohammed, through a statement from the Council condemned the ills of illegal drug distribution in the country and its impacts on the health of the nation, as he urged all stakeholders to play by the rules while trying to bridge the gap in drugs supply and the provision of quality healthcare commodities to the citizenry.
While identifying the challenges brought about by the pandemic which hampered medicines supply across the globe, he however stated that it is not yet uhuru, especially with the spike in COVID-19 cases from India, Brazil, and Turkey, as he advised pharmacists to raise the bar in practice and in provision of better healthcare delivery service.
“In spite of the challenging economic times we find ourselves in, I want to commend players in the Pharmaceutical industry for rising up to the occasion in bridging the gap in supply of healthcare commodities.
“I also want to seize this opportunity to remind us all that we are not yet out of the woods especially with the upsurge in COVID-19 cases in countries like India, Brazil and Turkey. As we approach the end of the second quarter of the year, we encourage pharmacists to be more committed to the task at hand and to raise the bar of practice by providing better quality service to Nigerian citizenry.
“In furtherance of PCN’s continuous efforts to ensure a good, safe and sanitized pharmaceutical environment, the National Enforcement Team visited Enugu State in the month of May, 2021. During the exercise, a total of 391 illegal were sealed, comprising of 90 pharmacies and 301 patent medicines shops for lack of compliance with PCN regulatory provisions in their and operation”, he explained.
Mohammed also hinted on the success of the just concluded 32nd/33rd Annual General Meeting and Scientific Symposium of the West African Postgraduate College of Pharmacists, held recently in Accra, Ghana, which appointed him as Chairman, Drug Advisory Council.
He also mentioned ongoing efforts towards the implementation of Pharmacist Consultant Cadre’ saying PCN in collaboration with Postgraduate College of Pharmacists (WAPCP) Nigeria chapter, organised a sensitization workshop on the issue.
“The PCN would like to encourage all pharmacies especially those in the public sector to rise up to the challenge of delivering exceptional pharmaceutical care to the teeming Nigeria public. This would firther reposition the pharmacists as value adding members of the healthcare team.”, Mohammed noted.
A recent study conducted by scientists from the Cincinnati Children’s Hospital and Medical Centre, has found vitamins deficiencies as one of the causes of migraines in children and adults.
The study led by Dr Suzanne Hagler, a Headache Medicine Fellow in the division of Neurology at Cincinnati Children’s Hospital and Medical Centre, drew from a database that included patients with migraines who, according to laboratory test had baseline blood levels checked for vitamin D, riboflavin, coenzyme Q10 and folate, all of which were implicated in migraines, to some degree, by previous and sometimes conflicting studies.
The team observed that a high percentage of children, teens and young adults with migraines appear to have mild deficiencies in vitamin D, riboflavin and coenzyme Q10 — a vitamin-like substance found in every cell of the body that is used to produce energy for cell growth and maintenance.
However, the findings reported on sciencedaily stated that further studies are required to expatiate on whether supplementation is effective in migraine patients in general. “And whether patients with mild deficiency are more likely to benefit from supplementation”, said Hagler.
Dr Haglera and her team also found that girls and young woman were more likely than boys and young men to have coenzyme Q10 deficiencies at baseline. They said that boys and young men were more likely to have vitamin D deficiency. However, it was unclear whether there were folate deficiencies, but they concluded that patients with chronic migraines were more likely to have coenzyme Q10 and riboflavin deficiencies than those with episodic migraines.
The research acknowledged previous studies that have indicated that certain vitamins and vitamin deficiencies may be important in the migraine process. Studies using vitamins to prevent migraines, however, have had conflicting success.
As Pharmanews marks 42 years of uninterrupted publication and service to healthcare professionals, manufacturers, policy makers, regulators, educators, students and indeed all stakeholders in the healthcare sector, our reporter, OMOLOLA FAMODUN, sought the opinions of some of our readers on what they think of the journal. Their views are presented below:
Pharmanews, foremost source of information and awareness on public health – Pharm. (Engr) Olatunji Koolchap
Pharmanews has become the foremost healthcare journal over time in Nigeria, West Africa and the Diaspora. It is a widely read pharmaceutical journal and has served as a source of information, education and publicity about medicines and current trends in public health and creation of awareness.
It is a medium for showcasing the activities and programmes of healthcare professionals and organanisations, local and international. Activities of all the technical arms of the Pharmaceutical Society of Nigeria (PSN), the Pharmacists Council of Nigeria (PCN), and the Nigerian Agency for Food and Drugs Administration and Control (NAFDAC) are so ubiquitous through this medium. Students affairs and young professionals practising also become visible through this medium.
Pharmanews has been consistently produced for 42 years and this is why I really felicitate with the publisher, Pharm. (Sir) Ifeanyi Atueyi, who is also the vice president of the Nigeria Academy of Pharmacy (NAPharm), on this august occasion. The organisation will continue to go from strength to strength, while I pray for sustainability and continuity.
God bless the publisher, the members of staff and Pharmanews Limited abundantly, Amen.
Pharm. Olatunji Koolchap
Pharmanews sensitised us to the practice environment, as students – Pharm Abiodun Ajibade FPSN (Immediate past chairman, PSN Oyo State Branch)
In my days at the pharmacy school of the University of Ibadan, in the late 80s and early 90s, there was always a big stack of Pharmanews kept in our school library, from month to month. It was always sent to the library in a cellophane bag and, as students, we had the opportunity to be familiar with several brands of pharmaceutical products advertised. As students, we were having information on the real world practice environment in Nigeria and the personalities in pharmacy leadership.
To me, I was getting the information about my future and that perhaps might have been the reason for my interest in coming forward for leadership positions in Pharmacy. All through my student life and after qualifying as a pharmacist, this journal remained like a rock of Gibraltar!
Congratulations to the entire team that has made this journal part of Pharmacy story for the past 42 years. Congratulations to our own highly revered and dear Sir Ifeanyi Atueyi, FPSN, for his resilience and commitment through thick and thin. Pharmanews is obviously part of our life and we celebrate this uncommon success over these four decades.
Pharmanews, paragon of resilience, consistency and editorial excellence – Pharm. Taiwo Olawehinmi
Taiwo Olawehinmi
Pharmanews represents, for me, the evidence of sheer resilience and admirable consistency. Being an advocate of representation for the pharmacy profession, it is great to see a national publication for pharmacists, by pharmacists.
It is also delightful to see the inter-professional collaboration reflected in some of the articles. It is my hope that Pharmanews will continue to ride on the waves of innovation and technology, to deliver premium health contents to healthcare professionals in Nigeria and beyond. Indeed, Pharmanews represents for me (and I believe many pharmacists), the quintessence of editorial excellence. I am excited about what the future holds for Pharmanews. Happy Anniversary, Pharmanews!
Pharmanews has excelled to become transgenerational – Pharm. Biola Paul-Ozieh FPCPharm, FPSN
Biola Paul-Ozieh
It is with great delight that I congratulate the Founder/Publisher, Sir Ifeanyi Atueyi, and the management team of Pharmanews on the 42nd anniversary of the foremost pharmaceutical journal.
I recall my brief stint at Pharmanews, between June 1995 and December 1996, as an associate editor. I joined Pharmanews then to edit the Nigerian Drug Index and thereafter worked with the editorial team for the monthly production of Pharmanews.
That was a trying period for Pharmanews and with the benefit of hindsight I can say our boss, Pharm. Ifeanyi Atueyi FPSN, displayed a rare sense of responsibility and courage in the face of daunting challenges. Many other pharma publication have come and gone but here we are celebrating Pharmanews at 42.
Sir Atueyi, I celebrate your tenacity of purpose, sense of commitment to Pharmacy, agility to serve, as well as your leadership role in attracting and retaining young and vibrant team players, who stood by you to cause a turnaround in Pharmanews. You are an epitome of determination, hard work, thoroughness and discipline.
The reinventing and repositioning of Pharmanews in the early 2000s as not only a pharma journal but a healthcare journal was a great achievement that has yielded better results and improved Pharmanews’ acceptability and coverage in the health sector. Pharmanews has therefore become transgenerational.
My stay at Pharmanews provided me with opportunities to write editorials and proofread scripts. It was not a wasted time as what I learnt then became useful when I served at the ACPN National Drug Information Centre in my early years in community pharmacy, as a member of the Drug Bulletin editorial team.
Once again, congratulations to you, sir, and your entire editorial team. Wishing Pharmanews greater strides in the years ahead.
Pharmanews still a pacesetter and record-breaker – Daniel Eze
I wish to unveil my knowledge, attitudes and perceptions (KAP) about Pharmanews. Wow! It is 42 years old. It has grown old, yet still waxing strong, breaking records and setting the pace in all and sundry.
For me, Pharmanews is the hub of public health information, an epitome of pharmacy practice, the pedagogy of food and nutrition, news and online polls. These attributes are in line with its mission statement: to be the number source of timely, accurate and insightful information relating to health and wellbeing of the general public. (The Pharmanews app is now on Play store, download and thank me later).
Pharmanews recognises innovation and active involvement of young pharmacists and pharmacy students in public healthcare, community health/social development, and drug research and development, among other evidence-based criteria. The publishing firm continues with such initiative to honour whoever emerges the Pharmanews Young Pharmacist of the Year and Pharmanews PANSite of the year through rigorous processes.
I see Pharmanews Nigeria as my pacesetter. I have no doubt to rate Pharmanews as a firm characterised by high level of excellence, uncompromised integrity, unbiased transparency and fair play.
The Food and Agriculture Organisation says Nigerians consume eight litres of milk annually which is below the World Health Organisation 210 recommendation.
The News Agency of Nigeria reports that WHO recommends milk consumption of 210 litres per person annually to prevent malnutrition.
It added that malnutrition is prevalent in Nigeria due to the low consumption of dairy products.
Why Nigerians Should Take More Milk –FAO
FAO Country Representative, Fred Kafeero, who stated this on Tuesday at the World Milk Day conference in Abuja, said Nigerian cattle produce less milk due to low investment and slow policy intervention.
He added that low milk production in Nigeria could be attributed to the cost of the processed milk which is largely imported.
“There are many structural and operational factors responsible for the majority of our people not having access to affordable milk.
“For some, it is the cost of the milk, many urban and rural folks can’t afford consuming milk on a regular basis. It is expensive, especially when you are talking about processed milk.
“Even the raw milk they consume is also expensive for the poor people in those rural areas.
“We acknowledge that the domestic production of milk of about 500,000 metric tons is quite low, the supply gap of 1.2 metric tons means that many people go without milk,” Kafeero said.
The Director-General of Raw Materials Research and Development Council, Prof. Ibrahim Doko, said Nigeria must scale milk production to meet local demand.
Doko was represented by a Deputy Director at the Council, Dr. Mary Abiaeye.
He said that domestic production does not meet daily capacity utilisation for the dairy companies and consumer demand while the shortfall is imported.
Doko added that Nigerian cows produce about 1.5 liters to two litres of milk daily compared to Kenya that produces 30 litres a day and Israel 45 to 60 litres a day.
He said Nigeria’s national dairy output per annum is 700,00 metric tons, while national demand is 1.3million metric tons per annum leaving a gap of 600,000MT.
“Nigerian local dairy sector relies mostly on milk production from subsistence Fulani pastoralists, few viable commercial dairy farms, and importation.
“The indigenous breeds of cattle have low genetic potentials (low growth rate and milk yield).
“This is possibly due to poor management system and stress of endless trekking in search of pasture,” he said.
The Federal Government has made an offer to increase hazard allowance for all health workers in government health establishments in the country.
Minister of Labour and Employment Chris Ngige said this while briefing newsmen at the end of a meeting between the Presidential Committee on Salaries(PSC), relevant Federal Government Stakeholders and Health Professional Association and Trade Unions on Wednesday in Abuja.
Chris Ngige
The meeting was called by the instance of the minister to discuss the issue of hazard allowance and retirement age for health sector workers in the government health establishments.
Ngige said that the resolutions reached during the meeting were fruitful.
”The Federal Government has moved up from the N5,000 monthly hazard allowance paid to all health workers in Nigeria and now offering 350 per cent and 600 per cent increments for junior workers and senior workers respectively.
”The government side led by the Minister of State for Budget and Planning gave a counteroffer to the earlier submissions made by the Nigerian Medical Association (NMA) and affiliate associations and the Joint Health Sector Unions (JOHESU).
“The Government side gave them that offer based on the realities that we have on the ground, that the economy is not doing very well and the capital component of the budget is actually being funded on borrowing. The earnings of the government have also drastically gone down.
“So, they are going back to their people with the government offer and they asked for two weeks adjournment to enable them to conclude consultation with their members and report back to us, “he said.
He added that they agreed that the offers should be left as it is until both parties go back for consultations with their members and return in two weeks time for further negotiations.
“But we moved from the N5000 hazard allowance per month, which was long forgotten until COVID-19 struck. During COVID-19, the government spent about N31billion for three months.
”So, I think the government side has offered things that are very reasonable, increasing the former positions of junior and senior health workers. Junior workers had 350 per cent rise and senior workers had about 600 per cent, ”he said.
Ngige also noted that the Federal Government has agreed in principle to increase the retirement age of doctors and other health workers from 60 to 65 years and 70 years for consultants.
The Senate on Tuesday passed a bill seeking to establish the Modibbo Adama University Teaching Hospital in Yola, Adamawa state.
Also passed was a bill to upgrade the Federal Polytechnic, Ilaro, to a full-fledged Federal University of Technology.
The passage of both bills followed consideration of two separate reports by the Committees on Health (Secondary and Tertiary), and Tertiary Institutions and TETFUND at plenary on Tuesday.
Chairman of the Committee on Health, Sen. Yahaya Oloriegbe said the bill, when signed into law, would upgrade the Federal Medical Centre, Yola, to a University Teaching Hospital.
According to him, the hospital would ensure the delivery of advanced health care services to the people of Adamawa State and its environs.
He said that the hospital would also contribute to the development of health sciences through research and teaching.
The Presidential Steering Committee on COVID-19 says it would proceed to deactivate the international passports of Nigerians who flouted the 2021 Health Safety Regulations as its concerns travel advisory.
The PSC Chairman and Secretary to the Government of the Federation, Mr. Boss Mustapha, disclosed this in Abuja.
”Pursuant to the travel advisory issued, I wish to inform you that the PSC has initiated series of sanctions against those that have violated the 2021 Health Safety Regulations.
”To this end, the PSC has published the names and particulars of over 200 violators that evaded the quarantine requirement.
“This is considered a serious infraction and the PSC will proceed to do the following: deactivate the passports of Nigerians involved, for a period of not less than one year; revoke the visas of foreigners that have abused our hospitality, and prosecute the violators where necessary.”
Mustapha warned that Nigeria cannot afford a third wave of coronavirus and will do everything to protect its territory.
“In the next couple of weeks, the PSC will focus on three major things, increase testing especially in the states, increase oxygen reserve capacity in case there is a third wave and increase vaccine acquisition drive,” he said.
On the travel ban against Emirates Airlines, the SGF said: “for some time now, Nigeria has been discussing with the authorities of the United Arab Emirates on the resumption of flights between the two countries.
“Nigerians must eschew sentiments by ensuring that friends, relations and associates arriving from countries of concern and indeed all countries obey the quarantine and post-arrival protocols. It is our duty to make sure this occurs.
In another development, PSC members took their second jab of the AstraZeneca vaccine.
Speaking during the vaccination, Mustapha said: ”some 12 weeks ago, the National Primary Health Care Development Agency began administration of the AstraZeneca vaccine across the nation with about two million persons vaccinated so far.
“We have since then intensified the creation of awareness to achieve a reduction of vaccine hesitancy and encourage all eligible persons to come out and take their second dose.
“Over the weekend, President Muhammadu Buhari and Vice President Yemi Osinbajo received their second dose of the AstraZeneca vaccine.
“Today, members of the PSC will receive their second dose during this briefing. This transparency is to underscore the safety of the vaccine.”
In agreement with the popular axiom that prevention is better than cure, Pharm. Obiageri Ikwu, a community pharmacist and managing director, Lopez Pharmacy and Stores, Lagos, recently conducted free medical screening for about 150 school children in Ojo, Amuwo Odofin area of Lagos.
The health campaign which was in collaboration with 21st Century Healthy Youths Initiative, a non-governmental organisation (NGO) featured a public lecture on malaria and other diseases, also had free deworming exercise for children, in commemoration of World Children Day 2021.
Children’s Day was first celebrated worldwide in October 1955, under the sponsorship of the International Union for Child Welfare in Geneva. First proclaimed by the United Nations General Assembly in 1954, it was established to encourage all countries to institute a day, firstly to promote mutual exchange and understanding among children and secondly to initiate action to benefit and promote the welfare of the world’s children. May 27 is traditionally the Children’s Holiday in Nigeria. First established by the United Nations in 1954, the day remains important in the lives of many Nigerian kids.
The free medical outreach according to Pharm. Ikwu was to deliver free healthcare services especially to children in the community with a strategic vision to protect them from the sicknesses that may impede their potentials.
She said in addition to the health benefits of the outreach, it is also a means of giving back to the community where she practices, adding that most people cannot differentiate who the pharmacist is from the quacks.
“The children’s day programme also targeted at catching them young because medicine accessibility and availability were also key, so physical medical checkup was done for the children and parents were encouraged to bring their sick children for consultation”, she stated.
Speaking further at the programme which had in attendance close to 150 children, teachers, parents and healthcare personnel, Pharm. Ikwu, emphasized the importance of health screening, saying “as a community pharmacist with passion for public health enlightenment, it is my responsibility to bring healthcare closer to the people and inform them about their health”.
On the impacts of the programme on the children, the organiser noted that it was important to catch the children young so that as they grow, they get more information about their health and also tell the coming generations about it.
While citing funding as the major challenge of her project, Ikwu remarked that the joy she derives from her relationship with the children has been her motivating factor. “As community pharmacists, we are the first port of call in any community, and we should make it a duty to affect the community where we practise and this is exactly what I enjoy doing most,” she said.
Underscoring the importance of the intervention, Dr Ikechukwu Meberim, who was one of the facilitators noted that regular health screening is important to the body, adding that the organiser recognised the prime place of children in the survival of humanity, which is why it is collaborating with an NGO to boost their health as well as get them prepared for future roles and commitments.
A beneficiary, Mr Sunmonu Akanni, Solid Ultimate Academy, expressed gratitude to the organiser as well as applauded the initiative, which according to him is targeted at the future stars of the country.
“To say that I am happy is an understatement for this kind of programme should not come once in a while but should be on a regular basis because as they say, health is wealth. I really appreciate the kind gestures from the initiative for giving succour to us and I pray for good health and God’s protection always,” he prayed.
90 per cent of brain growth and crucial aspects of its development occurs in the first 5 years of life. This is a critical window of opportunity to maximize a child’s learning potential through nutrition. Nutritional inadequacies during this critical period of brain growth, often lead to irreversible cognitive deficits culminating in impaired work productivity in adulthood.
Several nutrients in the diet are known to positively impact cognition and influence learning. Among all these nutrients however, DHA (Docosahexaenoic acid) in particular is recognised as essential for normal brain function. DHA is a major building block of the brain. It is the most abundant omega-3 poly-unsaturated fatty acid present in the brain and is found in oily fish such as salmons, sardines and tuna.
According to Bryan J. et al 2004 and Kuratko et al 2013, improving DHA status contributes to brain development by supporting these parameters: visual recognition, positive effects on motor skill development in early childhood, problem solving ability, improvement in short-term memory, reasoning and cognitive speediness.
Overwhelming evidence for the benefits of DHA comes from a recent review of some 50 studies by McCann JC and Ames BN . This review concluded that higher DHA in children’s diets translates into better brain function, especially for cognitive and visual function. An example of a rich, natural source of DHA is Breastmilk. Studies have shown that its high DHA content accounts for one of the main reasons why breast milk may improve the cognitive performance of children. Examples of DHA- rich foods include fish and seafood, poultry and eggs and DHA-fortified milk.
The benefits of DHA-fortified Milk
Intake of DHA of children in Nigeria varies considerably depending on the availability and access to seafood, especially those in land-locked areas. It is clear that most children have a very low dietary intake of DHA given their local plant-based diet.
For these reasons, supplementation of DHA in growing-up milk contributes to the availability of DHA for brain and cognitive development as well as for visual functions. A well-balanced growing-up milk can serve as a valuable addition to their daily diet and thus as a safety net, by providing a substantial part of daily-required (essential) nutrients including DHA.
Peak 456 Growing-up milk is specially formulated with DHA and other key nutrients to support brain development in children aged 4-6 years. It is quite versatile and can be added to a child’s meals for enrichment.
Worldwide, dairy plays an important role in nutrient security. The importance of milk as part of a healthy and adequate diet for children cannot be over-emphasized. However in some parts of Nigeria, children have little or no milk in their daily diet. As we celebrate World Milk Day, It is a call to action for us as a Nation to ensure to do more with milk as it can serve as a nutritional safety net in bridging the gaps between the RDAs and actual intake of some key nutrients such as DHA. Happy world milk day!
More than a third of summer heat-related fatalities are due to climate change, researchers said on Monday, warning of even higher death tolls as global temperatures climb.
Previous research on how climate change affects human health has mostly projected future risks from heatwaves, droughts, wildfires, and other extreme events made worse by global warming.
How much worse depends on how quickly humanity curbs carbon emissions, which hit record levels in 2019 but dipped sharply during the pandemic.
Global Warming May be Responsible For One in Three Heat-Related Deaths –Study
But a new study by an international team of 70 experts is one of the first – and the largest – to look at health consequences that have already happened, the authors said.
The findings, published in Nature Climate Change, were stark: data from 732 locations in 43 countries spread across every inhabited continent revealed that, on average, 37 percent of all heat-related deaths can be attributed directly to global warming.
“Climate change is not something in the distant future,” senior author Antonio Gasparrini, a professor of biostatistics and epidemiology at the London School of Hygiene and Tropical Medicine, told AFP.
“We can already measure negative impacts on health, in addition to the known environmental and ecological effects.”
The authors said their methods – if extended worldwide – would add up to more than 100,000 heat-related deaths per year laid squarely at the feet of manmade climate change.
That number could be an underestimate because two of the regions for which data was largely missing – south Asia and central Africa — are known to be especially vulnerable to extreme heat deaths.
The 100,000 figure is consistent with a recent analysis from the Institute for Health Metrics and Evaluations (IHME), published in The Lancet.
The IHME calculated just over 300,000 heat-related deaths worldwide from all causes in 2019. If just over a third of those deaths are due to climate change, as Gasparrini’s team reported, the global total would indeed be more than 100,000.
India accounted for more than a third of the total in the IHME tally, and four of the five worst-hit countries were in South Asia and central Africa.
The share of heat-related deaths attributable to global warming in the new study varied widely from country to country.
In the United States, Australia, France, Britain and Spain, for example, that percentage was roughly in line with the average across all countries, between 35 and 39 percent.
For Mexico, South Africa, Thailand, Vietnam and Chile, the figure rose above 40 percent.
And for half-a-dozen countries — Brazil, Peru, Colombia, the Philippines, Kuwait and Guatemala — the percentage of heat-related mortality caused by climate change was 60 percent or more.
A complex methodology combining health data and temperature records from 1991 to 2018, coupled with climate modelling, allowed researchers to contrast the actual number of heat-related deaths with how many fewer deaths there would have been without manmade warming.
The researchers found that it is not the increase in average summer temperature – up 1.5C since 1991 in the locations examined — that boosted death rates, but heatwaves: how long they last, nighttime temperatures, and humidity levels.
Also crucial is the ability of the population to adapt.
If 95 percent of the population has air conditioning, mortality will be lower. But if they don’t, or if farmers must work outside in 45C (113F) heat to feed their families, the impacts can be catastrophic.
Even wealthy nations remain vulnerable: in 2003, a relentless heatwave in western Europe claimed 70,000 lives.
Deadly heatwaves that might have occurred once a century before climate change kicked in could, by mid-century, happen far more frequently, scientists warn.
The burgeoning field of attribution climate science measures by how much, for example, a typhoon’s intensity, a drought’s duration, or a storm surge’s destruction has been amplified by global warming.
But little research has tried to do the same for human health, notes Dan Mitchell, a researcher at the Cabot Institute for the Environment at the University of Bristol.
“This shift in thinking is essential … so that global leaders can understand the risks,” he said in a comment in Nature Climate Change.
The Director-General of the World Health Organisation, Dr. Tedos Ghebreyesus, says smokers have up to a 50 percent higher risk of developing severe diseases and death from COVID-19.
Ghebreyesus said this in a message to commemorate World No Tobacco Day, globally marked on May 31 annually, to highlight the health risks associated with tobacco use and advocate effective policies to reduce tobacco consumption.
According to WHO DG, quitting is the best thing smokers can do to lower their risk from coronavirus as well as the risk of developing cancers, heart disease, and respiratory illnesses.
“We urge all countries to play their part by joining the WHO campaign and creating tobacco-free environments that give people the information, support, and tools they need to quit and quit for good.”
The director-general announced that WHO was taking advantage of digital tools to help tobacco users and had released the Quit Challenge chatbot and the Artificial Intelligence digital health worker Florence.
“The Quit Challenge gives daily notifications of tips and encouragement for up to six months to help people remain tobacco-free. It is available for free on WhatsApp, Viber, Facebook Messenger and WeChat,” he said.
According to him, the agency also released a “quitting toolkit” which includes these innovations, but also existing services such as brief advice from health professionals and national toll-free quitlines.
Globally, he stated roughly 39 percent of men and nine percent of women use tobacco; the highest tobacco use rates among men are currently found in the Western Pacific region at 49 percent and among women in Europe at 19 percent.
“As part of the “Commit to Quit” initiative, WHO calls for the adoption of bold policies that promote tobacco cessation; increasing access to smoking cessation services; raising awareness of the tobacco industry’s tactics; and support for consumers trying to stay away from tobacco.
“Currently, 29 countries are working with the agency to support tobacco cessation through national awareness campaigns and new digital tools,” he said.
He added that the efforts included policy review, training of health workers, the opening of specialised clinics, support for nicotine replacement therapies, and courses to quit smoking.
According to the UN health agency, the report that smokers are more likely to develop severe disease with COVID-19 compared to non-smokers triggered millions of people to want to quit tobacco.
But it said without adequate support, quitting could be incredibly challenging.
On World No Tobacco Day 2021, the agency reminded that the nicotine found in tobacco was highly addictive and created dependence.
It stated that this led to behavioural and emotional ties to tobacco use like having a cigarette with coffee, craving tobacco, and feelings of sadness or stress – making it hard to kick the habit.
However, with professional support and cessation services, tobacco users double their chances of quitting successfully.
Currently, over 70 percent of the 1.3 billion tobacco users worldwide lack access to the tools they need, and the gap in access to cessation services was further exacerbated in the last year as the health workforce was mobilized to handle the pandemic.
In a perfect world, an expectant mother should go into labour at 40 weeks. Yet sometimes the process doesn’t proceed as smoothly as expected, and baby runs late. Certain medical problems can make an extended pregnancy risky for the mother and the baby. The National Institute of Health and Care Excellence (NICE) has advised doctors to induce pregnant women early in a bid to reduce stillbirths.
The guideline says instead of these expectant mothers having to wait for 41 to 42 weeks before doctors start inducing them, they advised that it should be done earlier than that.
Nice said the shift followed an examination of recent evidence showing greater risks to the baby if pregnancies reached 42 weeks.
Health Agency Urges Doctors to Induce Pregnant Women Early to Prevent Stillbirths
One of the main studies examined (from Sweden and the Netherlands) was stopped early, because of the number of babies dying or being admitted to intensive care after late induction.
Medics and charities for those affected by stillbirth and infant deaths welcomed the move.
However, mothers’ groups warned that too many women were being pushed into stressful and traumatic inductions, without the right pain relief in place.
Until now, women have been offered induction on the NHS between 41 and 42 weeks, but recent evidence shows that babies are more likely to die if the pregnancy goes to 42 weeks or beyond.
The new guidelines say women should be induced as soon as possible when they hit 40 weeks in a bid to make birth safer for them and their child.
Those women who choose not to be induced at 41 weeks can continue with twice-weekly monitoring, but should be told that there is no evidence this can prevent poor outcomes for mother or baby.
Dr Paul Chrisp, director of the centre for guidelines at Nice, said: “It’s vitally important that pregnant women faced with the possibility of induced labour are offered advice based on the latest evidence.
“By advising induced labour one week earlier, we can help ensure that women and babies are safer from harm and have the best possible outcomes during birth.”
Dr Pat O’Brien, consultant obstetrician and vice president of the Royal College of Obstetricians and Gynaecologists, said: “We welcome an update to the NICE guidelines around inducing women’s labour.
“It’s been more than 10 years since the previous guidelines were introduced and it’s vitally important the new research published since then is acknowledged and the advice for women updated accordingly.
“This proposed update takes into account the increasing body of evidence that pregnancies that reach, or pass, 41 weeks are associated with a small increase in the risk of stillbirth and perinatal death and that induction of labour reduces this risk.
Justine Roberts, Mumsnet founder and chief executive, said women should be given an informed choice and adequate pain relief.
She said: “The consensus among Mumsnet users is that if induction at 41 weeks will save babies’ lives, this is great news.
“But inductions can be stressful and traumatic, especially if adequate pain relief isn’t in place, and some mothers spoke about agonising experiences of inductions when anaesthetists weren’t available to provide epidurals.”
Clea Harmer, chief executive of the Sands stillbirth and neonatal death charity, said: “Many bereaved parents have told Sands they believe earlier delivery might save their baby’s life. We hope this Nice review of the latest research evidence will help to get that judgement on timing right more often, avoiding more tragic baby deaths.
“We also hope this draft guidance will lead to better care and advice for parents whose baby has died, to minimise the chances of the same happening again in any future pregnancy.”
a) A lipoprotein that contains relatively small amounts of cholesterol and triglycerides and is associated with a decreased risk of atherosclerosis and coronary artery disease. It is also called alpha-lipoprotein
b) A lipoprotein containing a very large proportion of lipids to protein and carrying most cholesterol from the liver to the tissues
c) A lipoprotein that contains relatively high amounts of cholesterol and is associated with an increased risk of atherosclerosis and coronary artery disease. It is also called beta-lipoprotein
d) Large lipoprotein particle that is created by the absorptive cells of the small intestine. It transports lipids to adipose tissue where they are broken down by lipoprotein lipase
Lead Physician, Trauma Centre, Gwagwalada, Dr. Femi Onasanya, said the results of most studies with Genetically Modified Foods indicate that they may cause common toxic effects.
The expert, however, noted that studies were still on to ascertain their safety.
Onasanya, who stated this in an interview with the News Agency of Nigeria in Abuja, on Sunday said GMO foods might cause effects such as hepatic, pancreatic, renal, or reproductive effects.
He said it could alter the hematological, biochemical, and immunologic parameters of individuals consuming them.
“Genetic modification is a special set of gene technology that alters the genetic machinery of such living organisms as animals, plants, or microorganisms.
“Combining genes from different organisms is known as recombinant DNA technology and the resulting organism is said to be ‘Genetically modified’, ‘Genetically engineered’ or ‘Transgenic’.
“The principal transgenic crops grown commercially in the field are herbicide and insecticide-resistant soybeans, corn, cotton, and canola,” he said.
Onasanya said experts were working on developing foods that could have the ability to alleviate certain disorders and diseases.
He said GM foods “are useful in controlling the occurrence of certain diseases”, adding that by modifying the DNA system of these foods, the properties causing allergies are eliminated successfully.
“These foods grow faster than the foods that are grown traditionally.
“At times, genetically engineered food crops can be grown at places with unfavourable climatic conditions too,” Onasanya said.
He said that a normal crop could grow only in a specific season or under some favourable climatic conditions.
Onasanya said genetically engineered foods were reported to be high in nutrients and contained more minerals and vitamins than those found in traditionally grown foods.
According to him, the foods are known to taste better.
He said the reason for people opting for genetically engineered foods was that they had an increased shelf life and hence there was less fear of foods getting spoilt quickly.
Onasanya said the biggest threat caused by GM foods was that they could have harmful effects on the human body.
“It is believed that consumption of these genetically engineered foods can cause the development of diseases which are immune to antibiotics.
“Besides, as these foods are new inventions, not much is known about their long-term effects on human beings.
“Manufacturers do not mention on the label that foods are developed by genetic manipulation because they think that this would affect their business, which is not a good practice,” he said.
Onasanya said experts were also of the opinion that with the increase of such foods, developing countries would start depending more on industrial countries.
He explained that it was because it was likely that the food production would be controlled by them in the time to come.
He said that health risks associated with GM foods were concerns with toxins, allergies, or genetic hazards.
The World Health Organisation Regional Director for Africa, Dr. Matshidiso Moeti, says no fewer than 1.2 million people die annually due to exposure to tobacco smoke.
Moeti said this in her message to mark 2021 World No Tobacco Day with the theme, “Commit to quit.”
The News Agency of Nigeria reports that May 31 of every year is World No Tobacco Day.
She said the theme was to remind everyone that tobacco kills half of its users, and also harms nearly every organ in the human body.
She said that even smoking one cigarette a day can seriously harm a person’s health.
“Tobacco use can lead to lung, mouth, throat, oesophagus, stomach, bowel and other cancers.
”It increases the risk of chest and lung infections, heart disease, type 2 diabetes and other conditions.
“There is no safe form of tobacco.
“The theme this year is because the choice to stop tobacco use is in our hands.
“Millions of people have been motivated to quit tobacco during the COVID-19 pandemic.
“This is because of evidence showing tobacco smoking impairs lung function, making it harder for the body to fight off Coronavirus and other diseases,’’ she said.
Moeti said that of the 1.3 billion tobacco users globally, 60 per cent have expressed the desire to quit.
”But only 30 per cent have access to the tools to do so successfully,” she noted.
According to her, ”digital solutions can help to fill this gap and so at WHO we have introduced “Florence” a digital health worker who gives brief advice on how to quit and links people with the tools and solutions that can help.
“More than 75 million people in the African Region use some form of tobacco.
“This burden is likely to increase as consumer purchasing power improves coupled with intensive efforts by the tobacco industry to expand the African market,’’ Moeti said
The regional director said that public health advocates should therefore actively pursue counter-marketing campaigns that highlight the many risks of tobacco use.
She said that WHO was supporting countries to scale up programmes to help people quit tobacco at the primary health care and community levels.
”So far support to quit is available in primary health care facilities in 11 countries and in Angola, Botswana and Zambia these services are offered at no cost to consumers.
“National toll-free lines where tobacco users can call and get advice are available in six countries.
“Nicotine replacement therapy is sold in pharmacies in 19 countries with governments fully covering the costs in Eswatini, Mauritius and Seychelles.
“Nicotine replacement therapy is included in the essential medicines list in Algeria, Ethiopia and South Africa. Burkina Faso is implementing “mTobaccoCessation,” a mobile text messaging-based solution,’’ she said.
Moeti said that the promising progress now needs to be expanded to more countries in the WHO African Region.
She called on governments and communities to be alert to industry tactics to attract new users and keep people using tobacco, even when they are trying to quit.
“Products such as electronic cigarettes and nicotine pouches are highly addictive and not recommended as strategies to reduce tobacco use,’’ the regional director said.
She said that WHO remained committed to supporting Member States to meet their obligations under the WHO Framework Convention on Tobacco Control.
Moeti said it includes the development and implementation of programmes to promote quitting tobacco in schools, universities, health facilities, workplaces, and sporting environments.
She said that services to diagnose tobacco dependence and help people quit should be included as an integral component in national health and education programmes, plans and strategies.
“I call on governments to improve access to these services, using a combination of approaches, such as toll-free quit lines, nicotine replacement therapy (such as gum, patches, sprays and other products).
“Also digital solutions to empower people to quit. These interventions can be phased where resources are limited.
“Together, let’s support people with the tools and resources needed to successfully quit and to reduce the demand for tobacco. This will save lives, save money and create healthier societies,’’ Moeti said
Contrary to the widespread notion that the consumption of eggs increases the risk of heart diseases, due to its high content of cholesterol, a new research has found that about one egg per day could help us steer clear of cardiovascular conditions.
Although several early studies have shown that eggs intake can be harmful to people, especially patients of heart diseases, due to yolks’ high cholesterol content, but the new study suggested that eggs are also super foods with loads of protein, vitamins, phospholipids, and carotenoids.
Boiled Eggs
The recent research conducted by Chinese scientists from the School of Public Health at Peking University Health Science Center in Beijing, holds that a diet in which eggs are consumed on a regular basis may actually protect cardiovascular health.
Explaining the motive for the research, the Lead investigators Prof. Liming Li and Dr. Canqing Yu, noted that their team was motivated to embark on the study due to the high rate of cardiovascular conditions around the globe, with Nigeria having about 150.000 deaths annually, 84 million people affected in the United States and in China, an estimated “837,300 urban residents and 1,023,400 rural residents died from cerebrovascular diseases,” according to recent data.
To arrive at their findings, the team recruited 416,213 healthy participants from 2004-2008, who were free of cancer, CVD, and diabetes at baseline.
According to the findings, published in journal Heart and reported on Medical News Today , the participants reported how often they ate eggs — 13.1 percent of them admitted to daily consumption (about 0.76 eggs per day) and 9.1 percent said that they only indulged in eggs rarely (0.29 eggs per day) or not at all.
The findings further revealed that there was a median follow-up period of 8.9 years, during which new health diagnoses and deaths were recorded. During that time, 83,977 participants received a CVD diagnosis, and 9,985 people died due to CVD-related causes. Moreover, 5,103 major coronary events were recorded.
“The researchers’ analysis revealed that individuals who usually ate about one egg per day had a 26 percent lower risk of experiencing hemorrhagic stroke, a 28 percent lower risk of death due to this type of event, and an 18 percent lower risk of CVD-related mortality.
“Almost daily egg consumption — or around 5.32 eggs per week — was also linked to a 12 percent lower risk of ischemic heart disease, compared with people who never or rarely ate this food (amounting to approximately 2.03 eggs per week).
“The present study finds that there is an association between moderate level of egg consumption (up to 1 egg/day) and a lower cardiac event rate,” the study authors explained.
The takeaway from the recent study is that moderate consumption of eggs-one per day, is healthful rather than harmful, while excessive intake of eggs could be harmful to the human system.
British scientists in a breakthrough study, have found a natural replacement for chemotherapy in lung cancer patients, as they have demonstrated how tiny particles derived from tea leaves can restrain the growth of lung cancer cells, destroying up to 80 percent of them.
The researchers from Swansea University’s College of Engineering in the United Kingdom, found that these tiny particles, called “quantum dots,” are 400 times thinner than a human hair, and producing them from tea leaves is safe and non-toxic.
Previous studies have established that tea leaves contain a wide variety of compounds, including polyphenols, amino acids, vitamins and antioxidants.
Sudhagar Pitchaimuthu, lead researcher of the new study explained how their study confirmed previous evidence that tea leaf extract can be a non-poisonous alternative to making quantum dots using chemicals.
Pitchaimuthu explained that the only surprise, was that the dots actively inhibited the growth of the lung cancer cells.
Tea Leaf Particles Could Destroy Lung Cancer Cells – Scientists
Quantum dots can be made chemically, but this is complicated and expensive and has toxic side effects. The team, including researchers from KS Rangasamy College of Technology and Bharathiar University in Tamil Nadu, explored a non-toxic plant-based alternative method of producing the dots, using tea leaf extract.
To comprehend this analogy, the researchers mixed tea leaf extract with cadmium sulphate (CdSO4) and sodium sulphide (Na2S) and allowed the solution to incubate, a process which causes quantum dots to form.
They then applied the dots to lung cancer cells. They found that tea leaves are a simpler, cheaper and less toxic method of producing quantum dots, compared with using chemicals, confirming the results of other research in the field.
The study found that quantum dots produced from tea leaves inhibit the growth of lung cancer cells.
The researchers penetrated into the nanopores of the cancer cells and destroyed up to 90 percent of them. The CdS quantum dots derived from tea leaf extract showed exceptional fluorescence emission in cancer cell bioimaging compared to conventional CdS nanoparticles.
According to the research published in Sciencedaily, the researchers explained that quantum dots are therefore a very promising avenue to explore for developing new cancer treatments.
They also have other possible applications, for example in anti-microbial paint used in operating theatres, or in sun creams.
The Programme Manager, Anambra State Tuberculosis, Leprosy and Buruli Ulcer Management, Dr. Ugochukwu Chukwulobelu, says the burden of TB remained very high in the state.
According to Chukwulobelu, one in every 13 residents of Anambra is infected with tuberculosis.
He disclosed this on Friday during an advocacy visit to the State Director of the National Orientation Agency, Mr. Charles Nwoji, in Awka.
He said that the World Health Organisation’s 2020 global report indicated that Tuberculosis was one of the top 10 causes of death worldwide and Nigeria was classified as the number one country with a high burden of TB in Africa.
“No fewer than 18 Nigerians die every hour of TB and one case of untreated TB can infect between 10 and 15 persons per year.
“Anambra is among the high burden states in the country. It was estimated that one in every 13 residents has TB.
”In the first quarter of 2021, about 1,200 TB cases were diagnosed in Anambra and we still need to do more because there is a huge number of TB patients in communities that are not notified,” he said.
Chukwulobelu blamed the lack of funds and low awareness for the high burden of TB in the state.
According to him, it is imperative to seek the agency’s collaboration to sensitise the public on the prevention, causes and symptoms of tuberculosis.
“People’s knowledge of tuberculosis in Anambra is low; we have discovered that only a few residents have knowledge about tuberculosis.
“Tuberculosis, which is an airborne disease, is treatable and curable if detected early and we want to inform people through this collaboration that the diagnosis and treatment for TB are free in over 600 DOT centres in the state.
“Persistent cough of two weeks or more duration may be due to TB and needs to be further investigated to prevent spreading the germ to others.
“We are appealing to residents to report suspected cases of tuberculosis in their communities to the nearest healthcare centre for appropriate action,” he said.
Responding, Nwoji promised to support the programme by raising awareness of the challenges of the disease and the necessary measures to be taken to reduce its prevalence in the state.
He commended their initiative to seek collaboration with the agency for the purpose of awareness creation.
The News Agency of Nigeria reports that tuberculosis is a disease caused by a bacteria called Mycobacterium tuberculosis which usually attacks the lungs and could also damage other parts of the body.
It spreads through the air when a person with tuberculosis of the lungs or throat coughs, sneezes, or talks.
The International Pharmaceutical Federation (FIP) has urged the entire healthcare workforce to try as much as possible to be involved in efforts to improve diet and physical activity across populations.
In a statement signed by the organisation titled “Nutrition and weight management services: A toolkit for pharmacists” it emphasized the need for this is to prevent diseases and deaths from poor nutrition.
According to the statement, poor diets are responsible for more deaths than any other behavioural risk factor, including tobacco smoking, and up to five million deaths per year could be prevented if populations were more physically active.
FIP launches global pharmacy workforce transformation programme
Mr Gonçalo Sousa Pinto, FIP lead for practice development and transformation, said pharmacists are trained specially to promote health through pharmacological means.
He added that pharmacists are ideally positioned to help people to improve their nutrition and manage their weight because their easy, frequent accessibility means they can be on hand to help people maintain lifestyle changes, which is something people often find most difficult.
He further said that the FIP toolkit is set to support pharmacists in providing nutrition and weight management services.
“Pharmacists have an opportunity to make an even greater impact on the health of their communities by involving nutrition and weight management as a vital component of their approach to patient care. This toolkit aims to provide support and guidance for pharmacists to be proactive in having conversations on diet and weight with their patients, and we encourage more of the profession to adopt these services,” said associate professor Ingrid Gelissen, a report contributor from the University of Sydney School of Pharmacy, Faculty of Medicine and Health, Australia.
The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists and pharmaceutical scientists, and is in official relations with the World Health Organization. Through our 146 member organisations, we represent over four million practitioners and scientists around the world. Our vision is a world where everyone benefits from access to safe, effective, quality and affordable medicines and pharmaceutical.
The Presidential Steering Committee (PSC) on COVID-19 has recently listed the punishments for travelers who violated the COVID-19 travel guidelines on Thursday.
The Chairman of the committee, Boss Mustapha, disclosed this in a statement saying that their passports will be disabled for a period not less than one year; cancelation of visas/ permits of foreigners that have abused Nigeria’s hospitality, and prosecution under the 2021 Health Protection Regulations.”
The PSC also released the second batch of travelers who violated travel advisory, adding that they have been declared Persons of Interest after evading the mandatory seven-day quarantine for persons arriving from restricted countries.
The names of 132 violators were listed in the statement. This is in addition to the 90 violators that made the first list released on Sunday.
The statement reads partly, “Members of the public are by this notice advised that these persons of interest constitute an immediate health hazard to the society.
“They must therefore transport themselves safely, to the nearest state public health departments within 48hrs of this notice for immediate evaluation and call the Port Health Services, Federal Ministry of Health on 08036134672 or 08032461990 for further directions.
“The PSC shall, in addition, take further steps to sanction these violators. These steps include: disabling their travel passports for a period not less than one year; cancelation of visas/ permits of foreigners that have abused Nigeria’s hospitality, and prosecution under the 2021 Health Protection Regulations.”